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Older adults with infectious and chronic diseases, such as cardiovascular disease and 
human immunodeficiency virus (HIV), are at high risk for associated chronic 
comorbidities, which are associated with increased medical expenditures to cover 
treatment costs. The purpose of this study was to investigate (a) whether adults 65 or 
older with either HIV or cardiovascular disease were predisposed to increased medical 
expenditures versus adults 64 and younger, and (b) the impact of race and type of health 
service used on total direct medical expenditures incurred among adults with HIV or 
cardiovascular disease. A quantitative, deductive, retrospective cross-sectional design 
was used, and the behavioral model of health services use and the socioecological model 
were chosen as the study’s theoretical foundations. Analyses were conducted using 
binary logistic regression. Controlling for confounding variables of education and region 
of residence, the key findings were that adults ≥ 65 years had higher odds of incurring 
higher expenditures overall. White patients had higher odds of incurring higher 
expenditures for medication (OR 1.251), office-based visits (OR 1.433), inpatient visits 
(OR 1.245), and outpatient visits (OR 1.451) when compared to other races. Older adults 
with HIV had higher expenditures for medication and home health (OR 1.850); and older 
adults with cardiovascular disease had higher outpatient (OR 1.235), inpatient (OR 
2.142), and emergency room expenditures (OR 1.063). These findings might promote 
social change because assessing the influences of cost disparities on infectious and 
chronic diseases can help address variations in health care costs and can initiate the 
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Section 1: Foundation of the Study and Literature Review  
Introduction 
Cardiovascular disease is the leading cause of death among Americans and has 
become increasingly prevalent among older adults in the United States, resulting in 
increased economic and healthcare costs for several decades (American Heart 
Association, 2017; Centers for Disease Control and Prevention [CDC], 2018). 
Cardiovascular comorbidities, such as coronary artery disease and hypertension, are more 
prevalent among older adults (individuals 50 years and older), particularly among those 
living with HIV and AIDS, and can lead to organ and functional impairment, frailty, 
increased hospitalization, and even death (Abara et al., 2014). These comorbidities for 
HIV-infected individuals can also lead to increased medical expenditures (Shah, Gleason, 
& Luque, 2013). Though smoking, physical inactivity, and metabolic syndrome are 
traditional cardiovascular risk factors for cardiovascular events (Nery et al., 2013), there 
are higher rates of cardiovascular disease among individuals with HIV due to a 
combination of risk factors such as antiretroviral therapy and HIV-related inflammation 
(Tseng et al., 2012). Additionally, because of polypharmacy to alleviate the symptoms of 
conditions such as heart disease, hypertension and osteoporosis, there is an increased 
likelihood for dangerous drug interactions for HIV-infected older adults (Aidsinfonet.org, 
2014). Health care disparities related to chronic comorbidities like cardiovascular disease 
can result in increased medical expenditures, higher morbidity, lower survival rates, viral 
resistance, and diminished quality of life (Olem, Sharp, Taylor & Johnson, 2014).  
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I conducted this study to assess medical expenditure disparities among U.S. adults 
with HIV or cardiovascular diseases by investigating whether age, race, or type of health 
service used impacts medical expenditures in Americans diagnosed with HIV or 
cardiovascular disease aged 18 and over, particularly as it relates to older Americans. 
There has been a lack of literature on the health care needs and overall cost for HIV-
infected older adults and older adults with cardiovascular disease, but the aging HIV 
population along with those living with cardiovascular diagnoses indicates a need for 
further research. Thus, this study can increase awareness about the impact of increases in 
medical expenditures among older adults diagnosed with HIV or cardiovascular disease, 
which may lead to the implementation of targeted educational or intervention modalities, 
at the clinical and individual levels, by gender and/or ethnicity. In Section 1, the problem 
statement, research questions, theoretical foundations, significance, purpose, and nature 
of the study will be discussed. 
Problem Statement 
Cardiovascular disease is one of the leading causes of death among HIV-infected 
persons, with morbidity and mortality occurring earlier and more frequently among 
individuals aging with HIV than in uninfected individuals (Cournoyer et al., 2016; Tseng 
et al., 2012). The associated direct and indirect costs for cardiovascular disease are 
estimated to reach $818 billion and $276 billion, respectively, by 2030 (Benjamin et al., 
2017). Understanding the relationship between aging with HIV or cardiovascular disease 
and medical expenditures can provide opportunities for the development of tailored 
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evidence-based practice guidelines that can improve the morbidity and mortality rates of 
older U.S. adults living with these diseases. 
The incidence of cardiovascular disease among HIV-infected patients can range 
from 28% to 75%, as they are at an increased risk of disease incidence because of longer 
life expectancies due to antiretroviral therapies (Chastain, Henderson & Stover, 2015). 
Research shows that among patients with HIV infection, dyslipidemia, “an elevation of 
plasma cholesterol, triglycerides, or both, or a low high-density lipoprotein level that 
contributes to the development of atherosclerosis” (Goldberg, 2016, p. 1), is generally 
common and is associated with increased use of medical resources resulting in increased 
total medical expenditures over time (Richter et al., 2005). However, there is little 
information focused on the association between aging and the influence of the social, 
behavioral, and cultural aspects of living with HIV or cardiovascular disease. Moreover, 
there is insufficient data that addresses aging and the impact on the course and treatment 
of HIV (Sankar et al., 2011) or cardiovascular disease, especially as it relates to medical 
expenditures between American men and women, and particularly among older HIV-
infected African-American adults. Research has generally focused on individuals under 
the age of 65, omitting older men and women due to multicomorbidities and other 
exclusion factors (Jansen et al., 2015). As a result, there is limited data that addresses the 
health concerns of older men and women, who are also diagnosed with HIV or 
cardiovascular disease and are taking multiple medications to treat their illness (Jansen et 
al., 2015; Kebodeaux, Wilson, Smith, & Vouri, 2013). 
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This study builds on research conducted by Friedman and Duffus (2016) and Kim 
and Richardson (2014), which suggested that although most older Americans are 
Medicare health insurance beneficiaries, older adults, especially those with an HIV 
diagnosis, have higher risks for comorbidities than non-HIV-infected older adults. As a 
result, older HIV-infected individuals may need additional health insurance options to 
cover the out-of-pocket costs associated with the chronic diseases associated or run the 
risk of resorting to cost-saving strategies to mitigate exorbitant medical expenditures 
(Kim & Richardson, 2014), which can result in reduced treatment adherence. For 
instance, a 26% rate of nonadherence has been reported among older adults with 
cardiovascular disease (Ritchey et al., 2016). Reduced HIV treatment adherence is 
associated with increased medical expenditures, higher morbidity, and diminished 
survival rates and quality of life (Olem et al., 2014).  
Purpose of the Study 
Although research has been conducted on the impact of medical expenditure 
among Americans with cardiovascular disease, little research has addressed HIV 
diagnoses among older adults or the overlap of HIV diagnoses with cardiovascular 
comorbidities. The purpose of this quantitative study was to explore whether men and 
women 65 and older in the United States, with either an HIV or cardiovascular diagnosis 
are predisposed to increased medical expenditures when compared to adults aged 64 and 
under. Another focus of this study explores the impact of total medical expenditures 
between Blacks and Whites aged 65 and older with a diagnosis of HIV or cardiovascular 
disease when compared to individuals of the same race with the same diagnoses, aged 64 
5 
 
and younger. Finally, I also examined the effect that type of health service used has on 
the total medical expenditures incurred for patients with an infectious disease (HIV) 
versus patients with a chronic disease (cardiovascular disease).  
I used secondary data from the Medical Expenditure Panel Survey (MEPS) to 
determine whether disparities in health care expenditures exist among adults with 
diagnoses of HIV or cardiovascular disease. Increased awareness of medical expenditure 
disparities among older HIV-infected adults and older adults with cardiovascular disease 
can address the health and wellness concerns experienced by these individuals, 
particularly among those who experience added financial strain because of polypharmacy 
and other medical expenditures due to multicomorbidities. 
Research Questions and Hypotheses 
Research Question 1: What differences in total medical expenditures exist 
between American adults aged 65 and older, and American adults aged 64 and younger 
with a diagnosis of cardiovascular disease or HIV? 
H01: There is no significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Ha1: There is a significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Research Question 2: What are the differences in total medical expenditures 
between Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease 
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or HIV, when compared to individuals of the same race, with the same diagnoses, aged 
64 and younger? 
H02: There is no significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Ha2: There is a significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Research Question 3: What effect does type of health service (prescribed 
medicines, hospital inpatient stay, emergency room visits, office based medical provider 
visits, home health visits, and outpatient visits) utilized have on the total medical 
expenditures incurred for patients with an infectious disease (HIV) versus patients with a 
chronic disease (cardiovascular disease)? 
H03: There is no significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Ha3: There is a significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
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disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Theoretical Foundation  
Andersen’s Behavioral Model of Health Services Use 
The behavioral model of health service use developed by Andersen in 1968 was 
selected to help understand why older HIV-infected persons use health services and to 
determine whether all older HIV-infected persons, regardless of race, have equitable 
access to health care (Andersen, 1995). This framework was also chosen because it is 
commonly used to demonstrate an understanding of human development, behavior, and 
psychology (Petrovic & Blank, 2015) as well as individuals’ of use of health care 
services based on three main principles:  
1. predisposing factors that influence the use of health services and include 
demographic factors (such as age and gender), social structure (such as 
education, occupation and ethnicity), and health beliefs (such as attitudes, 
values, health and health care knowledge, the influence that health services 
have on current and subsequent perceptions of health services use, and need of 
health services)  
2. enabling factors (e.g., familial/community support and insurance access); and 
3. need factors (both perceived and actual, e.g. evaluated health status and 
perceived need and self-rated health). (Andersen, 1995; Babitsch, Gohl, & 
Lengerke, 2012)  
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These factors represent key concepts when analyzing the dynamics behind the cost of 
health care and medication adherence among the elderly.  
Socioecological Model 
The socioecological model provides details on the interaction between the 
interpersonal, intrapersonal, environmental, and policy structures (McLeroy, Bibeau, 
Steckler, & Glanz, 1988). This is important for older adults with HIV or cardiovascular 
disease diagnoses regarding the person–environment influential factors that may impact 
cost disparities (Reininger et al., 2012). The socioecological model is comprised of five 
factors that include (a) intrapersonal factors, which focuses on behaviors, attitudes, and 
knowledge on an individual level; (b) interpersonal factors, which focuses on the 
interplay of informal and formal social support systems and networks; (c) institutional 
factors, which emphasizes the role of social institutions and organizational characteristics 
both formally and informally; (d) community factors, which represent organizational, 
institutional and informal relationships; and e) public policy, which relates to policies and 
laws that are national, state and local in nature (McLeroy et al., 1988).  
There are some overlapping themes between Andersen’s behavioral model of 
health services use and the socioecological model framework in the 
predisposing/intrapersonal factors, enabling/interpersonal factors, and need/community 
factors. The predisposing/intrapersonal factors address the sociodemographic constructs 
and attitudes and beliefs of older adults with HIV or cardiovascular disease; the 
enabling/interpersonal factors address provider support, insurance, source of care, and 
income among Medicare beneficiaries; and the need/institutional and community factors 
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address the need for and accessibility to health care services for older HIV-infected 
individuals (Salihu et al., 2015) and individuals with cardiovascular disease. Because the 
focus of this review deals with person–environment factors, the public policy portion of 
the socioecological model was omitted from this discussion; however overarching themes 
in current policy within the U.S. were addressed in this study. 
  The factors of the socioecological model (see Figure 1) were incorporated into 
this discourse to provide an explanation for the relationships between gender, race and 
medical expenditure variables, and to bridge the gap among race and gender variables 
while also identifying areas such as education, health care access, and changes in current 
policy that can benefit from positive social change within this population. Finally, the use 
of these theories was critical to the understanding and interpretation of the findings in the 
data, which was obtained using a quantitative research. 
 
Figure 1. The socioecological model. 
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Nature of the Study 
A quantitative, deductive, retrospective cross-sectional design was used to 
analyze MEPS secondary data to gain an understanding of whether disparities in medical 
expenditures exist between adults aged 65 and older with a diagnosis of HIV or 
cardiovascular disease and adults of the same race and clinical diagnoses aged 64 and 
younger in the United States. This approach aligns with previous research (Mahmoudi, 
Jensen, & Tarraf, 2015; Xu & Borders, 2007), and supports the study’s problem 
statement by allowing for the review of a large sample size of the population (by year, 
race, and region) to calculate total medical expenditures for this cohort. The Agency for 
Healthcare Research and Quality (AHRQ) database provides data to assess the total 
medical expenditure. This website provides downloadable datasets from the MEPS on 
various topics including the use of health care, health care costs, hospital care trends, 
health insurance coverage, out-of-pocket spending, and patient satisfaction (AHRQ, 
2016a), which was helpful in determining total medical expenditures for this population.  
Independent variables for this study included race, age, gender, and type of health service 
used. This analysis determined whether disparities in cost and financial burdens existed 
by age and race, especially between Blacks and Whites, respectively. 
A retrospective cross-sectional quantitative design using binary logistic regression 
was conducted to determine whether a statistically significant relationship exists between 
the dependent variable (total medical expenditures) and the independent variables (age 
and race) as it relates to HIV and cardiovascular disease diagnoses, when accounting for 
confounding variables (e.g., education and region of residence). Binary logistic 
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regression was useful for this study because there are two or more independent variables 
(age and race) being used to examine the relationship between the predictor (independent 
variable) and the predicted variable (the dependent variable total medical expenditures).  
Literature Search Strategy 
Literature searches were performed in the CDC databases, CINAHL Plus and 
Medline databases from 2007–2017. Search engines included ProQuest, PubMed, 
BioMed Central, PLOS, AHRQ, Academic Search Complete and MEDLINE. Search 
terms and keywords used included health care cost, HIV, AIDS, older adults, economic 
impact, elderly, expenditure, Medicare, Socio-ecological model, Behavioral Model of 
Health Services Use, cardiovascular disease and cardiovascular. Seminal and peer-
reviewed literature focused on the epidemiology of cardiovascular disease and HIV 
disease among older adults. Current peer-reviewed literature included both quantitative 
and qualitative studies on medical expenditure trends among HIV and cardiovascular 
patients; health care disparities by age, race, and sex; access to health care and the role 
health care reform; comorbidities among older adults with HIV or cardiovascular disease; 
and the role of polypharmacy and medication nonadherence among older adult 
populations. Additionally, targeted searches for additional studies were performed using 
PubMed and manual searches were conducted using the reference sections of some 
retrieved articles.  
Literature Review Related to Key Variables and/or Concepts 
The purpose of this section is to review the current literature related to medical 
expenditures, as it pertains to adults aged 65 and older with a diagnosis of HIV or 
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cardiovascular disease, and to discuss the varying impacts of those costs within this 
population. This 65-year and older HIV-infected population was specifically chosen to 
explore total medical expenditure variations among those individuals listed as Medicare 
beneficiaries. 
HIV and Older Adults 
An increasing number of older persons in the United States are not only sexually 
active but are also not using contraceptives to protect themselves from the potential risk 
of HIV infection during intercourse (Brooks, Buchacz, Gebo, & Mermin, 2012; Emlet et 
al., 2015; Nguyen & Holodniy, 2008). As a result, these individuals may be unaware of 
the risks for HIV acquisition and because they are not routinely tested for HIV, older 
adults may also experience later HIV diagnoses because they may not be able to 
differentiate between the typical symptoms of aging and symptoms of HIV (Kebodeaux 
et al., 2013). HIV incidence in older Americans has increased over the last 20 years, with 
26% of Americans 55 and older either living with diagnosed or undiagnosed HIV 
infection since 2013 (CDC, 2017a). In addition, of the estimated 42% of older Americans 
currently living with HIV, 6% are 65 years and older (CDC, 2017a). The mean age of 
manifestation of multiple diseases associated with HIV was between 41 and 46 years 
(Guaraldi et al., 2011; Nsagha et al., 2015). The relative risk of cardiovascular disease 
among HIV-infected individuals increases among those aged 45 and older (Currier, 




Despite the statistics of older HIV-infected Americans, they continue to live 
longer lives because of advances in medical treatment (Balderson et al., 2013, Gebo & 
Moore, 2004). Further, the timeframe for the development of AIDS decreases with the 
rise in age (Mensforth, Goodall, Bodasing, & Coultas, 2014). Nevertheless, increased 
longevity can lead to increased risk and prevalence of age-associated comorbidities such 
as cardiovascular disease, chronic pulmonary disease, reduced density of bone minerals, 
renal disease, and hepatic disease (Balderson et al., 2013; Oursler et al., 2011). Although 
there have been advances in the treatment of HIV, older Americans remain vulnerable to 
delayed or missed HIV diagnoses, poor health outcomes when treated (Kearney, Moore, 
Donegan, & Lambert, 2010), and diminished ability to metabolize antiretroviral 
medications, which may increase toxicity and result in metabolic disturbances, end-organ 
damage (Deeks, Lewin, & Havlir, 2013), and greater mortality risks (Cahill & Valadez, 
2013). 
HIV as a Chronic Disease and Polypharmacy 
The use of combination antiretroviral therapy among HIV-infected individuals 
over the past two decades has resulted in a shift from an infection with a high mortality 
rate (Simone & Appelbaum, 2008), to a largely manageable, chronic condition 
(Balderson et al., 2013; Cahill & Valadez, 2013) underscored by improved rates of life 
expectancy along with increased incidence of HIV among older adults (Ghidei et al., 
2013; Greene, Steinman, McNicholl, & Valcour, 2014; Marzolini et al., 2011). Longevity 
among adults with HIV over the age of 50 has increased because of effective courses of 
highly active antiretroviral therapy, which has extended the survival rates of HIV-
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infected patients well past their 60s, 70s, and in some cases their 80s (Cahill & Valadez, 
2013; Gebo & Moore, 2004). It is estimated that three out of every four HIV-infected 
persons will be aged 50 and older by the year 2030 (Serrano-Villar et al., 2016). 
However, increased life expectancy among older HIV-infected individuals has resulted in 
the development of multiple chronic health conditions that result in age-associated 
comorbid disease burden, concomitant use of numerous medications (polypharmacy), and 
other medication-related problems (Edelman et al., 2013; Gleason, Luque, & Shah, 2013; 
Greene et al., 2014).  
HIV and aging also have a notable impact on the decline in both T-cell and B-cell 
functions, which accelerates the decline in the functionality of the immune system 
(Kearny et al., 2010). CD4+ cells, which encompass T-helper lymphocytes as well as 
other mononuclear cells, are actively targeted and infected by HIV, resulting in the 
annihilation of the immune system and their vital mediators (Nguyen & Holodniy, 2008). 
Older adults also experience a decline in thymic function due to age which, among HIV-
infected older adults, results in decreased CD4 count responses, as CD4 cell-mediated 
immune reconstitution relies on proper functionality of the thymus (Brooks, et al., 2012), 
because the thymus is the only organ within the human body that produces CD4+ T-cells 
(Gaardbo, Hartling, Gerstoft, & Nielsen, 2012; Jiang et al., 2014).  
The aging process could also be accelerated by the impact of the combination of 
HIV and antiretroviral therapy due to drug toxicity, systemic inflammation, coinfections, 
and multimorbidity (Gleason et al., 2013; Hentzien et al., 2016). The increase in 
comorbidities among this cohort of older HIV-infected individuals has also increased the 
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probability that they will increase their risk of polypharmacy to combat the burden of 
comorbid disease and HIV (Edelman et al., 2013). HIV-infected older adults have a 
greater risk of polypharmacy and medication-related problems such as adverse drug 
events, drug-drug interactions, potentially inappropriate mediations, and poor medication 
adherence when compared to non-HIV-infected older adults (Greene et al., 2014). 
Similarly, older HIV-positive males and females may be more likely to engage in 
polypharmacy than their non-HIV-infected age counterparts in the general population 
(Gimeno-Gracia et al., 2016). A higher percentage of HIV-positive patients are also 
prescribed non-antiretroviral therapy drugs, which include anti-infectives, analgesics, 
central nervous system drugs, gastrointestinal drugs, and respiratory drugs when 
compared to the similarly aged non-HIV-infected adults in the general population 
(Gimeno-Gracia et al., 2016).  
Cardiovascular Disease and Polypharmacy 
In the United States in 2017, 92.1 million adults had at least one type of 
cardiovascular disease, and by 2030, approximately 44% of adults in the United States 
may have some form of cardiovascular disease (Benjamin et al., 2017). With older adults, 
cardiovascular disease can become complicated with a combination of medications, 
which can result in adverse interactions for older adults (Nahin et al., 2009). 
Polypharmacy among older adults predisposes them to adverse drug events, which 
represents 25% of elderly hospital admissions and is the fourth leading cause of hospital 
admissions among this group of adults (Nanette et al., 2017). Polypharmacy also leads to 
medication nonadherence because older adults are prescribed a higher amount of 
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medications when compared to younger patients, which results in increased morbidity, 
mortality, and healthcare costs that can cost over $100 billion annually to the United 
States healthcare system (Nannette et al., 2017). A 2016 report showed a 26% 
nonadherence rate within this population (Ritchey et al., 2016). 
HIV and Cardiovascular Disease 
Cardiovascular disease has been the leading cause of death in the United States 
for several decades (CDC, 2016a). Cardiovascular disease is also one of the leading 
causes of death among HIV-infected persons (Cournoyer et al., 2016). Cardiovascular 
morbidity and mortality tend to occur earlier and more frequently among individuals 
aging with HIV than in uninfected individuals (Tseng et al., 2012), with an estimated 4.5 
times increased risk for sudden cardiac death and a 1.5 to 2 times greater risk of acute 
myocardial infarction (Al-Kindi et al., 2016; Feinstein et al., 2016; Miller et al. 2015; 
Serrano-Villar et al., 2016).  
Additionally, sudden cardiac death has occurred in HIV-infected persons at a rate 
of over 4 times the general population who presented with similar risk factors and tended 
to occur in older patients who had better HIV disease control (Tseng et al., 2012). 
Metabolic disturbances, such as dyslipidemia, hypertension, insulin resistance, and 
increased abdominal visceral adiposity, which occur as a result of HIV infection and 
antiretrovirals, have been found to increase ischaemic cardiovascular disease risk among 
HIV-infected persons (Gedela, Vibhuti, Ward, & Boffito, 2014). This is especially 
apparent among older HIV-infected individuals, as they are increasingly subjected to 
prolonged use of certain antiretroviral therapies such as protease inhibitors and 
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nucleoside reverse transcriptase inhibitors (Miller et al., 2015; Wigfall, Williams, 
Sebastian, & Glover, 2010). 
Despite concerns for older adults with HIV and comorbidities, older individuals 
have been omitted from clinical trials in favor of healthier and younger research 
candidates due to multicomorbidities and other exclusion factors (Jansen et al., 2015). 
Thus, there is little data available that addresses the health concerns of older people 
(Jansen et al., 2015). Even though there is a higher propensity of cardiovascular risk, HIV 
progression, and use of certain HIV medications among older HIV-infected adults, there 
is a lack of clinical guidance (Kebodeaux et al., 2013).  
Cardiovascular Risk Between HIV-Infected Men and Women 
In this review, studies on cardiovascular risk among HIV-infected adults, 
delineated by gender, had varying conclusions. For instance, Triant, Lee, Hadigan, and 
Grinspoon (2007) found that although acute myocardial infarction rates and 
cardiovascular disease risk factors were increased among HIV-infected patients when 
compared to non-HIV infected controls, these rates were particularly increased among 
women (Triant et al., 2007). An earlier study conducted by Dolan et al. (2005) also 
indicated a significantly increased risk factor for cardiovascular disease among HIV-
infected women in association with abnormal fat distribution. Additionally, Fredriksen-
Goldsen et al., (2013) found that lesbian and bisexual women had a higher risk of 
cardiovascular disease when compared to heterosexual women. Although there is limited 
data on cardiovascular disease in women living with HIV, the available data suggests that 
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there is an increased risk of cardiovascular disease in women when compared to men 
(Solomon et al., 2018). 
In contrast to the results on HIV and women, Losina et al. (2017) reported that 
without antiretroviral therapy, the lifetime cardiovascular disease risk for HIV-infected 
men was 12.9% and 9.0% for HIV-infected women. By the age of 60, the risk of 
cardiovascular disease among men was estimated at 20.5% among HIV-infected men and 
13.8% among HIV-infected women (compared to 12.8% for men and 9.7% for women in 
the U.S. population and 14.6% for men and 9.7% for women in the HIV-uninfected, at-
risk for HIV cohort (Losina et al., 2017). Losina et al. also suggested that as men 
continued to age with HIV, the projected lifetime risk of cardiovascular disease was 
estimated at 64.8% (compared to 54.8% and 59.1% for the U.S. general population and 
the HIV-uninfected, at risk for HIV cohort respectively). The projected lifetime risk of 
aging women with cardiovascular disease was estimated at 43.8% (compared to 46.1% 
and 36.7% for the U.S. general population, and the HIV-uninfected, at risk for HIV 
cohort respectively). Though these results are only projections, they indicate that as the 
HIV-infected adult population ages, the prevalence of cardiovascular risk tends to be 
higher among men than women. 
Medical Expenditures and Older HIV-Infected Adults 
Older people living with HIV (i.e., those 65 years and older) receive health 
insurance coverage from Medicare, with most beneficiaries of Medicare enrolled in fee-
for-service plans (Friedman & Duffus, 2016). However, the medical care cost for people 
living with HIV is still higher than non-HIV-infected persons (Guaraldi et al., 2013). 
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Research has suggested that those 65 and older with chronic health conditions had higher 
comorbidity risks than other Medicare beneficiaries enrolled in fee-for-service plans 
(Friedman & Duffus, 2016). With the rising costs of antiretroviral therapy treatment as 
HIV-infected persons live longer (Schackman et al., 2006), health care costs for people 
living with HIV are estimated to be between $10,000 and $40,000 annually (Friedman & 
Duffus, 2016). Older people living with HIV can encounter additional medical 
expenditures due to chronic multicomorbidities, which can range from $7,172 for 
Medicare beneficiaries with one chronic comorbidity to $32,498 for beneficiaries with 
three or more chronic conditions (Friedman & Duffus, 2016). 
Although the health expenses of older people are covered under Medicare, which 
covers their acute needs, additional health insurance options like Medigap and Medicare 
advantage may a be needed to cover additional out-of-pocket medical expenditures (Kim 
& Richardson, 2014). These out-of-pocket costs are influenced by chronic illnesses, 
which can increase as people living with HIV grow older with the disease (Kim & 
Richardson, 2014). Because of these growing out-of-pocket costs, older people living 
with HIV may also experience a rise in poverty rates due to the additional financial 
burdens they may encounter because of chronic multicomorbidities, which can result in 
incurred costs ranging between 19% and 35% of income spent for out-of-pocket health 
care expenditures among poor and near poor Medicare beneficiaries who are elderly 
(Kim & Richardson, 2014). Thus, older adults may resort to using cost-saving strategies 
such as skipping medication doses, splitting pills, and limiting or not refilling 
prescriptions (Musich et al., 2015) to mitigate these out-of-pocket expenditures. Other 
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less desirable cost-saving methods include the use of credit cards to finance their medical 
care expenditures (Grande, Barg, Johnson, & Cannuscio, 2013). 
Multiple factors can contribute to higher medical expenditures for older people 
living with HIV: length of time living with HIV infection, increased overall likelihood of 
changes to their antiretroviral therapy regimens due to drug toxicities, resistance, viral 
failure, nonadherence and regimen interruptions, mutations that can confer resistance, 
and non-HIV-related comorbidities and the treatments associated with them (Krentz & 
Gill, 2015). Further, there may be a correlation between multimorbidity and physician 
contact among the elderly, as individuals with multimorbidity were over 2 times more 
likely to have physician contact annually, with the number of visits increasing with each 
additional chronic comorbidity (Bahler, Huber, Brüngger, & Reich, 2015). Overall, the 
elderly population requires more specialized care and higher specialized care referrals to 
manage multimorbidity, which can further increase medical expenditures (Bahler et al., 
2015). 
Health care Policies and Older HIV-Infected Adults 
In the United States many individuals 65 and older receive health insurance 
coverage from Medicare. As the aging of the population of people living with HIV 
continues, many older people living with HIV may also be eligible for Medicaid health 
insurance plans to cover their treatment costs (Yehia et al., 2014). In 2010 approximately 
one-fifth of Medicare beneficiaries were dually eligible for Medicaid coverage (Lochner 
& Cox, 2013). In the past 50 years of Medicare services in the United States, Medicare, 
which is the single largest health insurance source, has accomplished its key goals of 
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ensuring health care access for the elderly and disabled and the protection against 
financial hardship as a result of the cost of health care (Davis, Schoen, & Bandeali, 
2015). However, there is the ongoing challenge of rising costs for both Medicare 
beneficiaries and the federal budget, stating that older beneficiaries over the age of 65 
spent on average, at least 15% of their income on health care due to their increased need 
for health care services for the treatment of chronic comorbidities (Davis et al., 2015). 
Moreover, these individuals faced additional financial risks as well as significant out-of-
pocket costs to pay for their health care services, especially among Medicare 
beneficiaries with income levels below 200% of the poverty level, that required 
supplemental health care coverage (Davis et al., 2015). 
In the United States Medicaid beneficiaries, of which greater than six million are 
65 and older, receive long-term health coverage and comprehensive health insurance 
from Medicaid based on functional limitation tests and state-specific standards for assets 
and income (Sommers & Grabowski, 2017). Because of the extensive health care needs 
of the elderly, health care coverage can be expensive, with the elderly accounting for 
almost two-thirds of Medicaid expenditures, even though they only represent one-fourth 
of Medicaid beneficiaries (Sommers & Grabowski, 2017). Thus, the elderly may possess 
dual eligibility for both Medicaid and Medicare to cover their medical expenditures 
(Sommers & Grabowski, 2017). 
Medicare part D  
Prescription medication expenditures can represent a costly portion of out-of-
pocket medical expenditures, among the elderly and those with extensive health care 
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needs, because of copayments and other monthly cash expenses (Davis et al., 2015; 
Grande, Barg, Johnson & Cannuscio, 2013;). On January 1, 2006. Medicare Part D was 
implemented to provide affordable coverage for prescription drugs to all beneficiaries of 
Medicare (Mahmoudi, Jensen, & Tarraf, 2015). Medicare has relatively high cost-sharing 
requirements which necessitates that beneficiaries procure additional cost-sharing 
assistance options, such as Part D, which offers low income and modest asset 
beneficiaries premium and cost-sharing support through the low-income subsidy program 
(Kaiser Family Foundation, 2016a). Medicare Part D has had a tremendous impact on 
assuaging the financial burden incurred by beneficiaries through the reduction of out-of-
pocket costs, increase in utilization of prescription drugs, decline in prescription drug 
non-adherence due to cost, and reduced rates of racial/ethnic disparities with regards to 
the utilization of prescription drugs and overall spending among senior beneficiaries of 
Medicare (Mahmoudi et al., 2015). The Medicare Part D plan does have one critical flaw; 
the coverage gap or “donut hole” which relates to the temporary limit of coverage for 
prescription drugs covered by the Part D plan (Kaiser Family Foundation, 2016a; 
Medicare.gov, n.d.a).  
This temporary delay in coverage can have a detrimental financial impact on the 
elderly diagnosed with HIV or cardiovascular comorbidities. This can be 
disadvantageous for older adults diagnosed with HIV, particularly if Medicare Part D 
eligible beneficiaries, who qualify for AIDS Drug Assistance Programs which assists 
with the prescription coverage gap or “donut hole,” are wait-listed due to state’s abilities 
to allocate funds to AIDS Drug Assistance Programs (Kaiser Family Foundation, 2017; 
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McManus, Engelhard, & Dillingham, 2013). Although Medicare Part D plan lowers out-
of-pocket spending, while improving access to, and use of cardiovascular drugs, Part D 
beneficiaries without financial assistance during the coverage gap are increasingly likely 
to discontinue or disrupt their cardiovascular medication regimens (Polinski et al., 2012). 
These delays amplify the risk of deterioration in corresponding improvements in health 
(Polinski et al., 2012), as well as negative health outcomes and medication nonadherence 
(Musich et al., 2015). 
  An increase in combination antiretroviral therapy prescription cost-sharing, which 
refers to out-of-pocket costs paid by Medicare Part D beneficiaries, represents a 
correlation with a modest decrease in the tendency of patients to maintain combination 
antiretroviral therapy adherence at clinically meaningful levels (Johnston et al., 2012). 
Johnston’s et al., (2012) investigations were analogous to research conducted by Das-
Douglas et al., (2009), who reported that among 125 HIV-infected homeless and 
marginally housed individuals with drug coverage receiving anti-retroviral therapy, 
increased cost of medications served as the premier barrier to antiretroviral medication 
interruptions among many of the Part-D covered survey respondents. 
Among Medicare seniors 65 and older, there is an increased disparity between 
Blacks and Whites in total annual spending on prescription drugs (Mahmoudi & Jensen, 
2014). Conversely, African Americans and Hispanic seniors reported cost as one of the 
primary reasons for prescription medication nonadherence; with this same group 
spending less on food and other basic requirements in order to afford prescription drugs 
(Mahmoudi & Jensen, 2014).  
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Affordable Care Act and American Health Care Act (Obamacare vs. Trumpcare) 
HIV medical care costs in the United States have substantially increased because of 
antiretroviral therapy; and with the aging population living longer due to improved life 
expectancies, the financial impact of caring for HIV-infected individuals will continue to 
increase (Schackman et al., 2006). The United States federal government spent $3.7 
billion dollars on HIV-related medical care in 1995; by 2005 the cost tripled to $11.6 
billion (Schackman et al., 2006). The federal budget request for domestic HIV for fiscal 
year 2017 was $27.5 billion (Kaiser Family Foundation, 2016b), which more than 
doubled the 2005 spending allocation for HIV-related medical care. Among Americans 
with cardiovascular disease, 7.3 million were uninsured in 2010; however, 7 million 
individuals who either had or were at risk for cardiovascular disease gained insurance 
coverage after the first year of the Affordable Care Act’s implementation (Wadhera & 
Joynt, 2017). Under the Affordable Care Act, this shift in coverage impacted healthcare 
utilization for individuals in low-income populations by increasing access to primary 
care, specialty care, and prescription drugs (Wadhera & Joynt, 2017). 
As the American population continues to age, and becomes more vulnerable to 
chronic comorbidities, there will be an increased need for additional intensive services, 
health care education, and integrated and transdisciplinary patient care, which will 
require legislative changes and the reform of service delivery processes to adequately 
address this population’s needs (Spitzer & Davidson, 2013). These changes are necessary 
for this population because there are substantial out-of-pocket expenditures for the 
elderly with chronic conditions, because of longer life expectancies (Hwang, Weller, 
25 
 
Ireys & Anderson, 2001; Meraya, Raval, & Sambamoorthi, 2015; Schackman et al., 
2006). Moreover, whereas former political administrations have provided generous 
spending allocations in the past, little is known about what future administrations will 
allocate toward this effort in the upcoming years. 
Health care coverage has now been extended to over 20 million individuals with 
additional funding streams allocated for public and community health centers with the 
Affordable Care Act (Himmelstein & Woolhandler, 2017); and although the Affordable 
Care Act has some flaws it has reduced medical expenditures, and improved overall 
quality of care for the insured (Manchikanti, Helm, Benyamin & Hirsch, 2017). 
Additionally, AIDS Drug Assistance Programs provide HIV-related medications and 
prescription drug access to HIV-infected individuals who are lower income, uninsured, or 
underinsured. AIDS Drug Assistance Programs also cover the true out-of-pocket costs for 
beneficiaries enrolled in Medicare Part D plans; allowing them to navigate the “donut 
hole” or coverage gap into catastrophic coverage, which assures reduced copayments for 
covered drugs for the remainder of the year (Kaiser Family Foundation, 2016a; McManus 
et al., 2013; Medicare.gov, n.d.b). The challenge with AIDS Drug Assistance Programs, 
however, is that they have been unable to meet the demand for their support, because of 
declines in annual federal and state allocations, and discretionary support, which has 
reduced the AIDS Drug Assistance Program budget over the years (McManus et al., 
2013). However, under the Affordable Care Act, which now allows for AIDS Drug 
Assistance Program spending on HIV drugs to count toward true out-of-pocket costs, 
eligible Medicare Part D beneficiaries can receive help to get through the coverage gap, 
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which is slated for elimination in 2020, until catastrophic coverage initiates (McManus et 
al., 2013). 
Mortality Trends and HIV-Infected Adults 
Antiretroviral treatment has led to the reduction of HIV-related mortality and 
morbidity, by prolonging suppression of plasma viremia, which has improved the quality 
of life of HIV-infected individuals (Johnston et al., 2012). Effective antiretroviral 
treatment, which has led to continual CD4 cell count improvements, has also increased 
life expectancy for HIV-infected persons that almost rivals the life expectancy for the 
general population (Smith et al., 2014). Nevertheless, the prolonged suppression of the 
AIDS virus has also caused a significant increase in non-AIDS mortality rates (Ingle et 
al., 2014). Non-AIDS infections, liver disease, malignancies and cardiovascular diseases 
are now major contributors to mortality among hospitalized HIV-infected patients, 
resulting in the most common cause of in-hospital deaths in the United States (Cowell, 
Shenoi, Kyriakides, Friedland & Barakat, 2015). As the HIV-infected population 
continues to age, there is an increased probability that these individuals will die from 
non-AIDS related comorbidities, such as cardiovascular and liver disease, non-AIDS 
defining cancer, and substance abuse, rather than from the actual AIDS virus (Cowell et 
al., 2015; Sackoff, Hanna, Pfeiffer, & Torian (2006). The prevalence rate of non-AIDS-
related comorbidities may be much higher in HIV-infected persons than those in the 
general population (Smith et al., 2014). HIV-infected persons in high-income settings are 
observed to have non-AIDS morbidities that are related to more traditional risk factors, 
such as smoking and hepatitis co-infection (Smith et al., 2014). Additionally, the risk of 
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antiretroviral-related adverse events like diabetes and dyslipidemia, as well as the risk of 
non-AIDS morbidities, may be increased among HIV-infected individuals because of 
persistent immunodeficiency, immune activation, immune dysregulation, and HIV-
infection associated inflammation (Smith et al., 2014).) Chronic renal disease and 
cardiovascular disease are the main prognostic factors for 5-year mortality as it relates to 
older PLHIV (Hentzien et al., 2016). Likewise, non-AIDS related malignancy had higher 
associations with age, and were strongest for heart/vascular and cardiovascular (Ingle et 
al., 2014). 
Mortality Trends and Costs Among Adults with Cardiovascular Disease 
Cardiovascular disease and stroke are among the most prevalent and costly health 
care issues in the United States, of which 160,000 of the more than 800,000 annual deaths 
occurring in people 65 and younger (CDC, 2018). One out of every six dollars spent on 
health care costs is attributed to the treatment of cardiovascular-related conditions (CDC, 
2018); and the annual cost of cardiovascular disease treatment and lost productivity in the 
United States was estimated at $236 billion and $316.6 billion dollars between 2011 and 
2013 (CDC, 2018; Kamal & Sawyer, 2017).  
The American Heart Association (2017a) estimates that by the year 2035 
cardiovascular disease costs will double among those aged 65 to 79 years, and triple 
among adults 80 years and older. Among adults aged 18 to 64 with incomes at or below 
138% federal poverty level, individuals with cardiovascular disease are twice as likely to 
be Medicaid beneficiaries than uninsured adults (Kaiser Family Foundation, 2012). 
Additionally, these individuals have higher Medicaid utilization rates and overall health 
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care spending when compared to enrollees without cardiovascular disease (Kaiser Family 
Foundation, 2012). 
Predisposing/Intrapersonal Factors 
Chronic conditions, such as cardiovascular disease, arthritis, and diabetes, have 
been infrequently studied among older HIV-infected men and women over the age of 65; 
as most studies have focused on HIV-infected persons at least 50 years of age (Friedman 
& Duffus, 2016). A large-scale study of HIV-infected persons aged 65 and older, 
revealed that when compared to non-infected Medicare beneficiaries, HIV-infected 
Medicare beneficiaries had a significantly higher risk of comorbidities and prevalence of 
disease which corresponded to increased medical expenditures because of complex 
medication regimens (Friedman & Duffus, 2016). In another study the behavioral model 
of health services use model, proved useful for providing understanding of the aging 
process of older people with HIV and cardiovascular disease, while also looking at the 
issue of trust attitudes toward health care providers and beliefs about the health care 
system and its relation to medication adherence (Petrovic & Blank, 2015). Results of the 
study revealed five barriers which served as hindrances to statins adherence among older 
people living with HIV and cardiovascular disease: (a) access to health care; (b) alcohol 
use and/or abuse; (c) mental health issues; (d) personal belief systems; and (e) lack of 
trust within the patient-physician relationship (Petrovic & Blank, 2015). 
Health care barriers denote an inverse relationship between receipt of medical 
care and delayed or inability to acquire health care due to financial reasons which 
ultimately delay the timely receipt of medical care, and subsequently affect medication 
29 
 
adherence (Kurichi et al., 2017).  Although sociodemographic variables such as age, 
gender, income, and insurance are highly correlated within most populations, poverty 
remains the underlying influencing factor concerning access to health care for the 
elderly/older adults rather than race (Fitzpatrick et al., 2004).  
The health beliefs of older adults also play a significant role when discussing the 
issue of trust toward health care providers, use of health services, and medication 
adherence; and is important with regards to older adults within the African American 
and Hispanic communities. When compared to older Whites, older Blacks exhibited a 
greater distrust of the health care system and physicians as a result of personal racism 
experiences, knowledge of overt historical racism within the health care system (such as 
the Tuskegee Syphilis Study), and the social and cultural divide between White 
physicians and Black patients, which contributes to health care disparities between these 
groups, and increases negative health outcomes for minorities (Musa et al., 2009). 
Furthermore, the existence of health care disparities among older African American and 
Hispanic Medicare beneficiaries, when compared to White Medicare beneficiaries, may 
cause issues accessing medical care, decreased probability of visiting a physician, 
inability to see a physician in a timely fashion for illness or injury, receipt of differing 
treatments based on race and ethnicity, decreased likelihood of high technology 
treatments for certain diseases, and reduction in medication use if prescription drug 




Regarding medical debt between older Black and White adults, research indicates 
that Blacks are more susceptible than Whites because they are more inclined to have 
poorer health, fewer financial resources, higher out-of-pocket expenses, increased burden 
of and lack of awareness about eligibility for the Medicaid enrollment process, 
experienced a combination of economic and social barriers to care, and have lower wage 
jobs with no health benefits for retirees which may result in medication non-adherence 
and circumvention of medical services, as well as reliance on higher costing need-based 
services when compared to Whites (Wiltshire, Elder, Kiefe, & Allison, 2016). Similarly, 
in 2012 Medicare beneficiaries allotted 14% of their total household spending toward 
health-related expenses; with beneficiaries experiencing higher than average health care 
spending ($4,722 vs. $2,772) and higher spending burden in lower average household 
budgets ($33,993 vs. $53,000) when Medicare households were compared to non-
Medicare households, respectively (Cubanski, Swoope, Damico, & Newman, 2014). 
These issues demonstrate the interpersonal/enabling factors that may serve as barriers to 
the use of health services among older adults with a diagnosis of HIV or cardiovascular 
disease.  
Need/Institutional and Community Factors 
Institutional and community factors also correlate with the perceived and 
evaluated need factors with regards to the use of health services among older adults. In 
the United States very little progress has been made toward properly caring for the 
elderly and establishing a health care system that is age-friendly; especially since 
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Americans, 65 and older, consume vast amounts of health care resources (Rowe and 
Fried, 2013). Furthermore, inadequate numbers of primary care service health care 
providers and an overall lack of geriatric medicine expertise within the United States 
health care workforce, also contributes to challenges in caring for this aging population 
(Rowe & Fried, 2013). This challenge underpins current statistics showing a reduction in 
income for physicians who obtain additional training to care for geriatric patients, 
because these individuals are almost exclusively covered by Medicare (Rowe & Fried, 
2013).  
Physicians may also be unaware of the potential for HIV infection among this 
population of patients, as older patients are less likely to report symptoms of HIV, as 
these symptoms oftentimes overlap with comorbidities that are commonly found in older 
adults (Linley et al., 2012). Interpersonal racial/ethnic barriers exist between minority 
patients and their predominantly non-minority clinicians/providers; and when compared 
to White patients, providers were more verbally dominant when speaking with Black 
patients, which may be because White patients are more verbal than Black patients during 
physician visits (Beach et al., 2011).  
Prevention services and messaging have usually targeted younger audiences, thus 
disparities common among minority races/ethnicities surrounding stigma, HIV testing 
barriers, diminished awareness of HIV risk, cultural and socioeconomic issues may also 
delay HIV testing among older adults and increase HIV infection risk (Linley et al., 
2012). These results suggest that reducing disparities in healthcare, particularly among 
minorities with an HIV diagnosis, can be accomplished by increasing effective 
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engagement and interaction efforts between providers and minority patients (Beach et al., 
2011).  
Definitions 
Definitions of some of the commonly used terms used in this paper, such as HIV, 
AIDS, older adults, and Medicare are provided. This is not an exhaustive list of terms 
used in this paper. Also, based on the nature of the research, other researcher authors may 
have used alternative definitions to define some of the terms used in this paper. 
AIDS: AIDS is the most severe phase of HIV infection. People with AIDS have 
such badly damaged immune systems that they get an increasing number of severe 
illnesses, called opportunistic infections (HIV.gov, n.d.). 
Cardiovascular disease: Conditions that involve narrow or blocked blood vessels 
that can lead to a heart attack, chest pain (angina), or stroke (Mayo Clinic, 2017). 
HIV: The virus that can lead to acquired immunodeficiency syndrome, or AIDS, 
if not treated. HIV attacks the body’s immune system, specifically the CD4 cells (T 
cells), which help the immune system fight off infections. Even with treatment, the 
human body cannot completely eliminate HIV (HIV.gov, n.d.). 
Medicare: Medicare is the federal health insurance program for people who are 
65 and older, certain younger people with disabilities, and people with End-Stage Renal 
Disease (permanent kidney failure requiring dialysis or a transplant, sometimes called 
ESRD). Medicare helps cover four specific services for these individuals: Medicare Part 
A (Hospital Insurance), Medicare Part B (Medical Insurance), Medicare Part C (Medicare 
Advantage Plans), Medicare Part D (prescription drug coverage) (Medicare.gov, n.d.c). 
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Multicomorbidities or multimorbidity: The presence of one or more chronic 
conditions, disorders, or diseases (Valderas, Starfield, Sibbald, Salisbury, & Roland, 
2009).  
Older individuals/elderly or older adults: In the context of this paper, these terms 
overwhelmingly refer to adults 65 years and older. 
Polypharmacy: The use of multiple medications and/or the administration of more 
medications than are clinically indicated; may represent unnecessary drug use (Hajjar, 
Cafiero & Hanlon, 2007). 
Assumptions  
Health care disparities among older adults commonly include age, gender, 
socioeconomic status and race/ethnicity (Fredriksen-Goldsen et al., 2013; The MacArthur 
Foundation Research Network on an Aging Society, 2009). Although physical and 
mental capacity tends to decline as a person ages, the degree of functional capacity 
experienced by older adults is more closely associated with socioeconomic factors that 
include educational attainment, race, and ethnicity rather than age (The MacArthur 
Foundation Research Network on an Aging Society, 2009). Similarly, higher education 
increased the likelihood of serenity, happiness, overall health, positive psychological 
states, protective health functions, and an increase in self-esteem in older adults (Murrell, 
Salsman, & Meeks, 2003).  
Based on this information, it can be assumed that older adults who have attained 
higher education, and are of a particular race and ethnicity, tend to have a much more 
robust socioeconomic disposition, are better able to navigate the Medicare system and its 
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complexities, and can afford the additional healthcare expenditures that occur due to 
living with chronic comorbid conditions. It can also be assumed that these individuals 
will have decreased mortality rates relative to older adults without these attributes. These 
assumptions are necessary in the context of this study as it can identify a specific 
disparity between older adults, particularly in the realm of education, which can provide 
insight regarding the roles of age, race and gender within this population in determining 
medical expenditures when combating multiple chronic conditions. 
Scope and Delimitations 
The research problem for this study aimed to identify whether age and race in the 
United States predisposes adult men and women with a diagnosis of HIV or 
cardiovascular disease to increased medical expenditures. Although various studies exist 
that indicate a higher prevalence of cardiovascular risk among HIV-infected women than 
HIV-infected men (Dolan et al., 2005; Fredriksen-Goldsen et al., 2013; Solomon et al., 
2018; Triant et al., 2007;); limited studies exist that look at the role of medical 
expenditures and the intersection of cardiovascular diagnoses versus HIV diagnoses 
among adults, particularly adults aged 65 and older. Although data available on adults, 65 
and older, is limited, what is known is that older adults with chronic multi-comorbidities 
can incur substantial medical expenditures and out-of-pocket health care expenditures for 
prescription medications and treatment (CDC, 2016b; Davis et al., 2015; Kim & 
Richardson, 2014; Meraya, Raval, & Sambamoorthi, 2015 Paez, Zhao, & Hwang, 2009). 
Moreover, a CDC report on multiple chronic conditions stated that 3 out of 4 Americans, 
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65 and older, have multiple chronic conditions that limit daily activities and requires 
ongoing medical attention (CDC, 2016).  
Another CDC report on chronic disease indicated that costs for people with 
chronic and mental health conditions accounted for 86% of the nation’s $2.7 trillion 
annual health care expenditures; and between 2012 and 2013 the total national annual 
cost for cardiovascular disease averaged $316.1 billion with $189.7 billion accounting for 
direct medical expenses and $126.4 billion accounting for lost productivity costs related 
to premature death (CDC, 2017b). Among most ethnic and racial groups in the United 
States cardiovascular disease is the leading cause of death (CDC, 2017b). Among 
minority groups, nearly half of non-Hispanic Black adults have some type of and are 
predisposed to higher rates of cardiovascular disease (Benjamin, Virani, Callaway, Chang 
et al., 2018; Jolly et al., 2010), and are twice as likely to die from preventable diseases, 
such as heart disease and stroke, as Whites (CDC, 2017c). Furthermore, the relative risk 
of cardiovascular disease among HIV-infected men and women is higher among those 45 
and older (Currier, Bartlett, & Bloom, 2018; DeSocio et al., 2008).  
Due to the small population of older HIV-infected individuals, as well as the 
stigma and ageism that many within this population may experience, it is uncertain 
whether older HIV-infected adults, especially those who develop the disease later in life, 
are readily sharing their health status due to the fear of experiencing prejudice and 
discrimination (Emlet, 2006). I conducted this study to investigate the disparities that 
exist among older adults with cardiovascular disease or HIV diagnoses, because this 
population is infrequently studied; and to determine whether racial disparities also 
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correlate with higher medical expenditures for older adults 65 years and older when 
compared to adults 64 years and younger with HIV or cardiovascular disease diagnoses. 
The limitations associated with this study are those primarily associated with studying 
older populations and which can also impact this study’s generalizability to younger 
populations. Delayed HIV and cardiovascular disease diagnoses, inaccurate 
differentiation between typical symptoms of aging and symptoms of HIV, and general 
unawareness of the risks of HIV acquisition are some of  the barriers that may not only 
prevent accurate reporting of HIV transmission among older adults, 65 years and older 
(Kebodeaux et al., 2013), but discrimination and prejudice associated with an HIV 
diagnosis in old age (Emlet, 2006), may also preclude these individuals from readily 
disclosing their diagnosis in the MEPS survey. Additionally, medication non-adherence 
due to polypharmacy for comorbidities, mortality and morbidity risks, underreporting, 
lapses in memory, and inaccurate reporting of conditions can result in decreased data for 
this patient population.  
Significance, Summary, and Conclusions 
This section examined various topics affecting health care and use of health care 
services among older HIV-infected adults with cardiovascular disease as described in 
currently published literature. 
HIV incidence in older Americans, especially adults 65 years and older, has 
continued to increase because of: later diagnoses, the aging of HIV-infected adults due to 
advances in medical treatments, and effective courses of antiretroviral therapy. As older 
adults continue to age with this chronic disease, they also become increasingly 
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susceptible to comorbidities not only because of age, but because of medication non-
adherence, drug toxicity, systemic inflammation, coinfection, and multimorbidity due to 
antiretroviral therapy. Although the number of Medicare beneficiaries with HIV has 
tripled from the 1990s until 2014 (45,520 to 120,000 respectively), less than 1% comprise 
the total Medicare population, and only 21% of beneficiaries with HIV are over the age 
of 65 (Kaiser Family Foundation, 2016c). However, Friedman and Duffus (2016) 
investigated chronic health conditions in HIV-infected Medicare beneficiaries aged 65 
years and older from a sample population of 29,060,418 and found that 24,735 (0.09%) 
were HIV+. Thus, there is some disparity regarding the precise HIV-infected older 
population, aged 65 and older, who are Medicare beneficiaries.  
Health reports indicate that chronic diseases, such as cardiovascular disease, 
account for a significant portion of the health and economic costs in the United States, 
with annual health care expenditures for chronic and mental conditions totaling 90% of 
the $3.3 trillion allotted for the nation’s annual health care expenditures, or $10,345 per 
individual (CDC, 2018; Foy & Mandrola, 2018). Additionally, the prevalence of poor 
diet, the obesity epidemic, high blood pressure, and the rise in Type 2 diabetes contribute 
to the major risk factors associated with stroke and heart disease (American Heart 
Association, 2017). The direct costs of cardiovascular disease continue to increase for 
White, Black, and Hispanic Americans; however, the indirect costs of cardiovascular 
disease, which include lost productivity at home and in the workplace, have a greater 
impact on White Americans and individuals between the ages of 45 and 64 years 
(American Heart Association, 2017). 
38 
 
In recent years, cardiovascular disease has become the leading cause of death in 
the United States, not only among non-HIV-infected individuals, but also among aging 
HIV-infected adults (CDC, 2016a; Cournoyer et al., 2016). Among older HIV-infected 
men and women, multimorbidity and age-related chronic conditions occur at higher rates 
than non-HIV-infected men and women in the same age bracket (Guaraldi et al., 2015, 
Cournoyer et al., 2016, Kim & Richardson, 2014). As a result, older HIV-infected adults 
are prescribed non-antiretroviral therapy drugs, such as anti-infectives, analgesics, central 
nervous system drugs, gastrointestinal drugs, and respiratory drugs (Gimeno-Gracia et al., 
2016) to combat their comorbidities. This may cause older HIV-infected adults to have 
increased risk factors for polypharmacy and medication-related problems such as adverse 
drug events, drug-drug interactions, potentially inappropriate medications and medication 
nonadherence (Greene et al., 2014).  
Aging HIV-infected adults may also incur additional out-of-pocket medical 
expenditures because of chronic multi-comorbidities. Researchers estimate that elderly 
poor and near poor Medicare beneficiaries, can incur costs ranging from 19% and 35% 
for out-of-pocket expenditures (Kim & Richardson, 2014); and older Medicare 
beneficiaries, aged 65 and older, can spend at least 15% of their incomes on health care 
for treatments related to chronic comorbidities (Davis et al., 2015).  
While an increase in prevalence of self-reported chronic conditions has occurred 
in old-old, midlife, and earlier old age, individuals with multiple chronic diseases also 
experience substantial out-of-pocket spending, particularly because of drug costs (Paez, 
Zhao, & Hwang, 2009). Among older adults aged 65 and older, different combinations of 
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chronic conditions may correlate with varied out-of-pocket spending burdens; and older 
adults who had 3 or 4 chronic conditions were more likely to incur higher out-of-pocket 
spending burdens when compared to older adults with only 2 chronic conditions (Meraya, 
Raval, & Sambamoorthi, 2015). 
In a 2005 study, Paez et al., (2009) reported that medications/drugs for individuals 
were the costliest out-of-pocket medical expenditure; with older adults 65 years and 
older, with multiple chronic conditions, spending an average of $1,292 each year. Over a 
decade later, the Kaiser Family Foundation (2016b) developed a fact sheet of the Centers 
for Medicare and Medicaid Services Medicare Part D prescription drug benefit 
projections for 2017 which stated that during the “donut hole” or coverage gap, Medicare 
beneficiaries would have to cover their drug costs until their total out-of-pocket 
expenditures reached $4,950 before they would be eligible to enter the catastrophic 
coverage threshold, wherein Medicare covered 80% of drug costs. The expenditures 
depicted during this twelve-year time period illustrate rising out-of-pocket prescription 
drug costs for older adults. Consequently, older adults who are unable to accommodate 
costly out-of-pocket medical expenditures may engage in cost-saving strategies such as 
skipping medication doses, splitting pills and limiting prescription refills (Musich et al., 
2015).  
As Congress continues to deliberate whether or not to repeal and replace the 
Affordable Care Act, it is evident that out-of-pocket spending, and overall total medical 
expenditure disparities, among older adults must be adequately addressed. If Congress 
succeeds in repealing the Affordable Care Act, millions of Medicare beneficiaries, 
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especially those with multiple chronic comorbidities, could face even greater financial 
hardships, resulting in medication nonadherence and negative health outcomes (Musich 
et al., 2015).  
The major themes in the literature all indicate that multiple factors do contribute 
to rising medical expenditures for older HIV-infected adults and older adults with 
cardiovascular disease diagnoses and tends to be an ongoing challenge for this 
population. As it pertains to this study, although available literature investigating the 
health care needs and overall cost for HIV-infected older adults with cardiovascular 
disease is limited, the continuous aging of the HIV population, along with those living 
with cardiovascular diagnoses, indicates the explicit need for further research in this area.  
This study primarily seeks to explore: the educational practice gap that may add 
to medical expenditure disparities among older adults with cardiovascular and HIV 
diagnoses; the role of shared decision-making between the patient and the clinician to 
discuss treatment risks and benefits, that allow for the expression of patient values and 
preferences; and the conferring of mutual responsibility and information exchange 
regarding decisions around treatment and care (Barry & Edgman-Levitan, 2012). It is 
hoped that this research study can add to those discussions. In section 2 this gap in 
practice will be addressed regarding its relation to race, age, gender and economic factors 
among older adults with HIV or cardiovascular disease.  
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Section 2: Research Design and Data Collection 
Introduction 
The purpose of this study was to address whether age, race, or type of health care 
service affected medical expenditures in older Americans diagnosed with HIV or 
cardiovascular disease. The behavioral model of health service use and the 
socioecological model were used to look at: predisposing/intrapersonal factors, which 
addressed the sociodemographic constructs of the study; enabling/interpersonal factors, 
which identified potential barriers to health services among adults diagnosed with HIV or 
cardiovascular disease; and need/institutional and community factors, which correlated 
with the perceived and evaluated need influences that impact the use of health services 
among these individuals. The current section of this study describes the methodology 
used to investigate the research problem. It provides a thorough look at the various 
interrelated factors, such as age, gender, race, and economic status that may highlight 
existing disparities in health care expenditures among adults with a diagnosis of HIV or 
cardiovascular disease. The components of this section will also address the research 
design and rationale, the study’s methodology (the study population, sampling methods 
and procedures, instrumentation, limitations to secondary data analysis), ethical issues, 
and threats to validity. 
Research Design and Rationale 
A quantitative, deductive, retrospective cross-sectional design was used to 
examine the relationship between race, age, or type of health service used and the 
corresponding health care expenditures incurred among adults diagnosed with HIV or 
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cardiovascular disease within the U.S. population. Potential cofounding variables 
included education and region of residence. The independent variables included race, age, 
gender, and type of health service used. The dependent variable was total medical 
expenditures related to health care. 
A quantitative research design was chosen for this study for various reasons. First, 
quantitative research designs are applied when researchers are interested in testing 
objective theories through the examination of the relationships among variables 
(Creswell, 2009). This design also allows for the deductive testing of theories and 
incorporates protections against bias, controls for alternate explanations, and allows for 
the generalization and replication of research findings (Creswell, 2009). This design 
differs from a qualitative research design which, although inductive in nature, is used to 
explore and understand the meaning of social or human problems as ascribed by 
individuals or groups (Creswell, 2009). Second, quantitative research designs can involve 
nonexperimental inquiry strategies, such as surveys, to provide a numerical description of 
the opinions, attitudes, and trends of a population by investigating, and generalizing from 
a subset of the study population (Creswell, 2009). Third, nonexperimental quantitative 
research strategies can include a cross-sectional design, which is frequently used in 
survey research (Frankfort-Nachmias, Nachmias, & DeWaard, 2015).  
The strengths attributed to the use of cross-sectional designs include the use of 
probability samples and its occurrence in natural, real-life settings, which increases 
external validity; its widespread use in the social sciences and survey research; the use of 
statistical analyses to overcome various methodological limitations; and its ability to 
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derive and describe causal relationships between variables (Frankfort-Nachmias et al., 
2015). The limitations of the cross-sectional design is that it occurs at a single time-point, 
with no indication of the sequence of events (Levin, 2006); the direction of causation 
must be inferred theoretically or logically because of the inability to manipulate the 
independent variable; and it is difficult to make unambiguous inferences, such as 
causality, because of inadequate control over competing explanations (Frankfort-
Nachmias et al., 2015; Levin, 2006). The study’s quantitative, deductive, retrospective 
cross-sectional design supports the problem statement and answers the research 
questions: 
Research Question 1: What differences in total medical expenditures exist 
between American adults aged 65 and older, and American adults aged 64 and 
younger with a diagnosis of cardiovascular disease or HIV? 
Research Question 2: What are the differences in total medical 
expenditures between Blacks and Whites aged 65 and older with a diagnosis of 
cardiovascular disease or HIV, when compared to individuals of the same race, 
with the same diagnoses, aged 64 and younger? 
Research Question 3: What effect does type of health service utilized have 
on the total medical expenditures incurred for patients with an infectious disease 
(HIV) versus patients with a chronic disease (cardiovascular disease)? 
This design allowed for the review of a large sample size of the population (by year, race, 
and age) to examine total medical expenditures for adults with HIV or cardiovascular 
disease diagnoses within the MEPS. Additionally, to maximize external validity and 
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study result generalizability, a nonprobability or convenience sampling method as well as 
stratification by gender, race, and age was used. Because I used secondary data for this 
analysis, there were no time and resource constraints on the study population, as the use 
of existing data was less expensive than the collection of primary data (see Frankfort-
Nachmias et al., 2015).  
Methodology 
Population 
The population for this study was obtained from the MEPS and compares adults 
65 or older who were diagnosed with HIV or cardiovascular disease to adults diagnosed 
with HIV or cardiovascular disease under 64, residing in the United States between 2011 
and 2015. Adults 18 and older with a diagnosis of HIV or cardiovascular disease were 
extracted from this population subset and analyzed for the purposes of this study. The 
total sample used for analysis for both cardiovascular disease and HIV diagnoses was 
5,753, of which 3,038 were males and 2,715 were females. Based on the availability of 
data, different subsamples were used to calculate each of the six household-reported 
medical events and the total sample representation used for this study is as follows: 5,598 
cardiovascular disease; 155 no cardiovascular disease (97.3% had cardiovascular 
disease); 5,572 no HIV and 181 with HIV (3.1% had HIV). 
Sampling and Sampling Procedures Used to Collect Secondary Data  
For this study, household component and medical conditions data were derived 
from the MEPS sampling frame from 2011 through 2015 and pooled to increase sample 
size. Selection criteria for this study included adults (18 and older) with HIV/AIDS or 
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cardiovascular disease. MEPS collects data using probability sampling, specifically a 
complex random sampling method that is derived from the National Health Interview 
Survey respondents (Davis, 2015). This type of sampling procedure is also known as a 
mixed sampling design, as it involves both a cluster sampling and stratified sampling 
design for sample selection (Davis, 2015; Kothari, 2004). The National Health Interview 
Survey is conducted by the National Center for Health Statistics and the survey data 
provides a representative sample of noninstitutionalized civilians throughout the United 
States and includes an oversampling of Black and Hispanic individuals (Davis, 2015).  
MEPS is a large-scale annual household survey that is nationally representative of 
the noninstitutionalized U.S. civilian population and includes medical providers, 
employers, families, and individuals (Davis, 2015). The household component involves 
an overlapping panel design to collect detailed information on health conditions, health 
status, access to care, socioeconomic and demographic characteristics, healthcare 
expenditures, health insurance coverage, patient care satisfaction, use of medical services, 
and employment (Davis, 2015). The medical conditions component consists of 
household-reported medical conditions information derived from a nationally 
representative sample of the noninstitutionalized U.S. population during participant 
interviews. Medical conditions described during the telephone interviews were recorded 
verbatim and translated by professional coders into fully-specified International 
Classification of Diseases, 9th Edition, Clinical Modification codes, which also included 
V codes and medical conditions. Diagnosis condition codes were collapsed into 3-digit 
code categories from the International Classification of Diseases codes to preserve 
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respondent privacy and confidentiality (AHRQ, 2017a). Clinical classification codes, 
which are aggregated International Classification of Diseases condition and V codes, are 
also included in the MEPS data and are used to group analogous conditions. These 
classification codes are generated using Clinical Classification Software provided on the 
Healthcare Cost and Utilization Project website (AHRQ, 2017a). Like the household 
component and medical condition data, prescribed medicines purchased by the 
respondent and their family members, as well as expenditures related to prescribed 
medications and associated medical conditions, are also household-reported from a 
nationally representative U.S. noninstitutionalized civilian population.  
To determine the sample size, a 95% confidence level was used, which 
corresponded to a z-value of 1.96. A 95% confidence interval indicates that the 
probability that the population mean lies within +/-1.96Z score interval occurs with 
roughly 95% confidence (see Frankfort-Nachmias et al., 2015). A total sample of 5,753 
adults, aged 18 and older, with a diagnosis of HIV or cardiovascular disease were 
included in this study. The sample size was determined using a complex samples function 
that used the G*Power calculation tool (Faul, Erdfelder, Buchner, & Lang, 2009). Using 
an a priori power analysis, and a two-tailed test, sample size calculations were 
determined as:  
effect size f2 = 0.05;  
α = probability of Type I error = 0.05;  
β = probability of Type II error = 0.2;  
power = 1- β = 1-0.2= 0.8.  
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Therefore, the total sample size for the study group, N, was estimated to be 160. 
The strength of the conclusions among different group relationships or differences 
among variables is identified by the effect size. A p-value demonstrates the probability of 
making a Type I error as a result of the rejection of the null hypothesis (Marshall & 
Jonker, 2010). Although it provides no indication of effect size and does not provide 
information on the impact of the effect size on the entire population (Marshall & Jonker, 
2010), it is still important to report both the p-value and the effect size to allow for an 
increased understanding of the study’s findings. An alpha level of 0.05 was used to 
indicate that the chance of a significant difference takes place at least 5% of the time, 
which is not a true difference and occurs because of chance. The power level of 0.8 was 
used to increase the chances of a statistically significant difference in the study findings 
while rejecting the null hypothesis and thereby avoiding Type II errors. 
Instrumentation and Operationalization of Constructs 
The instrument that was used for this survey, the MEPS, is an instrument known 
for its content validity and reliability through weighted estimates, sampling strata, and 
primary sampling units (AHRQ, n.d.). This instrument was appropriate for this study 
because surveys, particularly health surveys that collect continuous information can be 
used as a surveillance mechanism, which can provide data on health conditions, health-
related knowledge or risk factors, attitudes, and behaviors for the time frame in which 
they are conducted (Shi & Johnson, 2014). Validity and reliability have also been 
demonstrated using the Taylor-series linearization method, which is a method commonly 
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used for complex survey data to estimate the covariance matrix of the regression 
coefficients as well as standard errors of estimates (AHRQ, n.d.).  
Over a 2.5-year timeframe, data are first collected using a preliminary contact and 
then proceeded by a series of five rounds of interviews (Davis, 2015). Data on medical 
expenditures and use are captured from each household by computer-assisted personal 
interviewing technology over a two calendar-year period (Davis, 2015). Continuous and 
current estimates of health care expenditures are provided through a series of data 
collection rounds that are launched on a new sample of households each subsequent year 
to provide overlapping survey data that is then combined with other ongoing panels 
(Davis, 2015). National estimates of health service use and health care expenditures are 
calculated using the weights provided in the MEPS data files (Davis, 2015). MEPS also 
includes medical provider component data collected from hospitals, physicians, 
pharmacies, and home health care providers who are identified by respondents who 
complete the MEPS-household component (AHRQ, 2017a). This data supplements 
and/or replaces information obtained on both the medical and financial characteristics of 
medical events that is collected from survey respondents regarding any provision of 
health care over the past survey year (AHRQ, 2017a). MEPS public use data files can be 
downloaded free of charge from the MEPS website and permission is not required for use. 
To supplement the data collected by interviewers, paper questionnaires available 
in both English and Spanish are periodically administered to households. The Adult Self-
Administered Questionnaire, which is a mail-back survey administered during Rounds 2 
and Rounds 4 of the data collection periods with a 1-year gap between self-administered 
questionnaires, is administered to adult participants of each household residing in the 
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United States who are 18 years and older (AHRQ, 2017b, Cheak-Zamora, Wyrwich, 
McBride, 2009). The self-administered questionnaire was first fielded in 2000 and 
includes questions from the SF-12, Consumer Assessment of Health Plans, and attitude 
items (AHRQ, 2017b). The EuroQOL 5D was included in the self-administered 
questionnaire, but it is no longer administered in MEPS (Hayes, Bhandari, Kathe, & 
Payakachat, 2017). The SF-12v2, which is used to measure health-related quality of life 
is comprised of two component scores: (a) mental component summary, which focuses 
on participants’ social activity, emotional state, and level of distraction limitations and (b) 
the physical component summary, which encompasses the general overall health, 
mobility limitations, work, other physical activity as well as the pain limitations of 
participants. Both component scores measure the latent concepts of physical and mental 
health (Hayes et al., 2017). Each component is scored on a scale of 0-100 with a mean of 
50, with higher scores denoting better health (Hayes et al., 2017).  
The SF-12v2 is an appropriate instrument to answer the research questions 
because literature has indicated that it is an accurate and well-established scale that has 
been used across several disease areas (Khanna, Jariwala, & West-Strum, 2015; 
Montazeri et al., 2011). Additionally, the scale is renowned for its reliability and validity 
and has been examined in numerous studies (Hayes et al., 2017; Khanna et al., 2015; 
Montazeri et al., 2011). Estimates for reliability and validity for the MEPS survey 
instrument SF-12v2 were first presented by Cheak-Zamora, Wyrwich, and McBride 
(2009), and the instrument’s cross sectional and longitudinal validity was demonstrated in 
a national representative database. The SF-12v2 had relatively high estimates for validity 
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and reliability for the general populace regarding the mental and physical component 
scores based on the 2003–2004 MEPS data. Further, the SF-12v2, while complex, was 
not only brief, but was found to be far superior than the currently employed single 
question measures (Cheak-Zamora et al., 2009). Additionally, Hayes et al. (2017) found 
that the SF-12v2 is both a reliable and valid measure of health-related quality of life. 
Both components of the SF-12v2, mental component summary and the physical 
component summary, demonstrated high internal consistency (Cronbach’s alpha and 
Mosier alpha > 0.8) and moderate and high test-retest reliability (mental component 
summary intraclass correlation coefficient: 0.64; physical component summary intraclass 
correlation coefficient: 0.73) during analysis. To determine the construct and criterion 
validity of the SF12v2, analyses using Spearman rank correlation coefficient and the 
Tukey’s test found that there was strong and moderate concurrent validity in both the 
physical component summary and the mental component summary when examining the 
number of chronic conditions within the study (Hayes et al., 2017). 
I used Cronbach’s alpha to evaluate the reliability of the data, which indicates the 
propensity of correlation between items and their contribution to a composite score 
(Hayes et al., 2017). Cronbach’s alpha was calculated to determine the internal 
consistency reliability of the physical component summary and the mental component 
summary. Intraclass correlation coefficients was used to evaluate the test-retest reliability 
of the physical component summary and the mental component summary. Construct and 
criterion validity were also evaluated for this study. Construct validity, which indicates an 
instrument’s ability to measure the concept for which it was designed, was determined 
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with the Spearman rank correlation. Concurrent validity, which indicates the ability of a 
particular measure to parallel the established measure of the same construct, and 
predictive validity, which demonstrates how well one measure’s score predicts the results 
of a second similar measure, were both evaluated as part of the criterion validity (Hayes 
et al., 2017). To measure concurrent validity, the Tukey’s test was applied, as it worked 
well to evaluate areas of difference between disparities in total medical expenditures by 
race among older adults with HIV and cardiovascular comorbidities. Binary logistic 
regression analysis was used to assess the predictive validity. 
Operationalization of Variables 
The primary independent variables for this study are race, gender, age, and type of 
health services used (independent exposure variables). The covariates of this study were 
income level/poverty status. Variables remain consistent across survey time-periods, with 
the year allocation changing annually to denote the new year of the survey. The 
proceeding descriptions of the operational variables included in this study were expressed 
using 2014 survey data. Race, identified by code 188, was measured on a nominal scale, 
and is represented by the following values: 1, White-no other race reported; 2-Black-no 
other race reported; 3, American Indian/Alaska Native-no other race reported; 4, 
Asian/Native Hawaiian/Pacific Islander-no other race reported; and 6, Multiple races 
reported. Gender/Sex, identified by code 187, was also measured on a nominal scale, and 
is represented by the following values: 1, Male; 2, Female. The types of health services 
analyzed in this study included prescribed medicines, hospital inpatient stay, emergency 
room visits, office based medical provider visits, home health visits, and outpatient visits. 
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Dental visit services and other medical expenses (e.g. medical equipment, supplies, 
glasses, and other medical items) were omitted from this analysis. 
Total family income was measured on an interval level, identified by code 1452, 
and represented the following values: 01, -$48,666- -$2,789; 02, $0.00; 03, $1 - $22,200; 
04, $22,201 - $44,724; 05, $44,725 - $82,006; 06, $82,007 - $542,785. Family income 
was used to calculate poverty status in relation to the federal poverty line (based on 
household size and composition) with poverty status determined as follows: poor (less 
than 100% below the poverty line) near poor (100% to less than 200% of the federal 
poverty line), middle income (200% to less than 400% of the federal poverty line), and 
high income (greater than or equal to 400% of the federal poverty line) (Meraya et al., 
2015). Insurance coverage, identified by code 2197, was measured on a nominal scale, 
are was represented by the following values: (1), <65 any private; (2), <65 public only; 
(3), <65 uninsured; (4), 65+ edited Medicare only; (5), 65+ edited Medicare and private; 
(6), 65+ edited Medicare and other public only; (7), 65+ uninsured. The independent 
variables (age, gender, income level/poverty status, race, and type of health services 
used) were controlled for in adjusted models when examining their association with total 
health care expenditures. 
The selection criteria for this study were diagnoses of HIV or cardiovascular 
disease. Cardiovascular disease diagnoses were identified by CCCODEX value codes 
100, 101,103, 104 and 108, which represented the following cardiovascular conditions 
respectively: acute myocardial infarction, coronary atherosclerosis and other heart 
disease, pulmonary heart disease, other and ill-defined heart disease, and congestive heart 
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failure, non-hypertensive. The CCCODEX for cardiovascular conditions were recoded 
and delineated as CCCODEX1 to include all potential cardiovascular conditions into one 
unified category prior to analysis. HIV diagnoses were identified by the CCCODEX 
value code 005. The independent variables in this study represented both nominal 
(categorical) and interval (continuous) level measurements. As such, nominal level data, 
which represent qualitative variables, were converted to quantitative variables via 
appropriate coding mechanisms prior to analysis.  
Dependent variable.  
Total medical expenditures, inclusive of out-of-pocket spending burden, were the 
dependent variables of this study. Expenditure variables were measured at the interval 
level and extracted from the MEPS data which collects data on payers and types of 
services, while also capturing health care expenditures (Meraya et al., 2015). The sources 
of payment included: self or family, other federal government, Medicare, state/local 
government, Medicaid, Workers’ Compensation, private insurance, other insurance, 
Veterans Administration/CHAMPVA, other private, TRICARE, other public, and sum of 
payments. For the purpose of analysis, these were recoded as follows: none, any private 
insurance, Medicare, and public insurance. To determine per capita annual total health 
care expenses in the MEPS, payments by payers and across types of services are 
computed for each person (Meraya et al., 2015). 
Operationalization of Potentially Confounding Variables 
A potential moderator of the disparities that exist between gender, age, and race 
and health care expenditures is the attainment of an education. Education attainment 
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denoted as year of education or highest degree for all Americans within the MEPS survey 
is designated as a nominal categorical variable, and was defined as follows: (-9), not 
ascertained; (-8), don’t know; (-7), refused; (-1), inapplicable; (1), less than/equal to 
eighth grade; (2), ninth through 12th grade, no high school diploma; (3), GED or 
equivalent; (4), high school diploma; (5), some college, no degree; (6), associate degree: 
(occupational, tech, vocational); (7), associate degree: (academic program); (8), 
bachelor’s degree (BA, AB, BS, BBA); (9), (master’s, professional, doctoral degree); 
(10), child under 5-years-old. For the purposes of analysis, these were recoded as follows: 
less than elementary, elementary through eighth grade, ninth through 12th grade, high 
school diploma or GED, some college through bachelors, and master’s or doctorate.  
Another potential confounding variable is region of residence within the United 
States. This variable was measured on a nominal categorical scale and denoted using the 
following values: -1, inapplicable; 1, Northeast; 2 Midwest; 3, South; and 4, West. Other 
potential confounding variables, for which data were not collected included health care 
access and health literacy. Potential confounding variables were necessary to include in 
this study to provide a possible explanation for the relationships between the dependent 
and independent variables that were not readily detected or assessed (see Creswell, 2009). 
Data Analysis Plan 
Statistical analyses for this study were conducted using R (version 3.4.4) 
statistical software. MEPS data is collected from all 50 states and the District of 
Columbia using a complex multistage sample design that involves clustering, unequal 
selection probabilities, and stratification and have unequal weights (Machlin et al., 2010). 
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Data analysis for this type of complex sample design necessitates statistical software that 
considers the sample design and estimation complexities which are required when 
considering computing variances/standard errors of MEPS estimates such as STATA, 
SAS, SUDAAN, or WESVAR (Machlin et al., 2010). Data for this study was pooled over 
a five-year period to yield a sample size large enough to analyze and generate estimates 
that are reliable.  
MEPS data is drawn from the same sample geographic areas, with sample 
respondents remaining consistent for at least two consecutive years (Machlin et al., 
2010). Earlier MEPS data estimates were based on the periods wherein sample 
respondents were a part of the noninstitutionalized civilian population, and researchers 
were strongly encouraged to account for those individuals who were in-scope for a 
portion of the data collection period in their analyses (Machlin & Yu, 2005). For the 
timeframe for which data is used in this study only persons who were in-scope during the 
data collection survey periods (noninstitutionalized civilians) were included in the data 
set and identified with the code positive person-level weights. MEPS data accounts for 
attrition of survey respondents, that is those who were only in-scope for a portion of the 
data collection period, by adjusting the panel weight variables included in the file. 
To account for inconsistencies in data collection for this study, pooled data were 
screened and cleaned by classifying and matching already provided personal-level 
identifiers across each survey timepoint to identify missing and erroneous data which can 
affect the validity and reliability of the study’s outcomes. To identify skip patterns and 
missing data values frequency tables and cross-tabulations of all variables included in the 
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study’s analysis were run. Original variables were recoded, and a new dataset was created 
to include all pooled data and syntax documentation of all recoded variables were 
performed (Cheng & Phillips, 2014). Additionally, to assure consistent variance structure 
when pooling MEPS geographic sampling data across several timepoints, Taylor series 
variance estimation methods were applied during analysis as they appropriately reflect 
the complexities of the MEPS design (Machlin et al., 2010). 
An overview of the research questions for this study are as follows: 
Research Question 1: What differences in total medical expenditures exist 
between American adults aged 65 and older, and American adults aged 64 and younger 
with a diagnosis of cardiovascular disease or HIV? 
H01: There is no significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Ha1: There is a significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Research Question 2: What are the differences in total medical expenditures 
between Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease 
or HIV, when compared to individuals of the same race, with the same diagnoses, aged 
64 and younger? 
H02: There is no significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
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when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Ha2: There is a significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Research Question 3: What effect does type of health service (prescribed 
medicines, hospital inpatient stay, emergency room visits, office based medical provider 
visits, home health visits, and outpatient visits) utilized have on the total medical 
expenditures incurred for patients with an infectious disease (HIV) versus patients with a 
chronic disease (cardiovascular disease)? 
H03: There is no significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Ha3: There is a significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
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This study was a retrospective cross-sectional quantitative analysis that assessed 
MEPS expenditure data and used: (a) descriptive statistics, to describe and explain 
characteristics of the study variables; (b) binary logistic regression to predict the 
relationship between the independent variables (age, race, gender, and type of health 
service used) and the dependent variable (total medical expenditures) among individuals 
with the diagnoses of HIV or cardiovascular disease. For each research question, 
descriptive statistics was used to assess the means, standard deviations, and score ranges 
for the study’s demographic variables, R (version 3.4.4) software was used. 
Research Question 1 and Research Question 2 was addressed through the 
utilization of two-way analyses following a binary logistic regression model with the 
dichotomous expenditure variable used as the criterion for each regression. Research 
Question 3 was analyzed using multivariate analyses following a binary logistic 
regression model with the dichotomous variable used as the criterion for each regression. 
Binary logistic regression was conducted to determine if a statistically significant 
relationship exists between the dependent variable (total medical expenditures) and the 
independent variables (age, race and gender) as it relates to HIV or cardiovascular disease 
diagnoses, when accounting for confounding variables (e.g., education, insurance, and 
region of residence). For the binary logistic regression analysis, a confidence level of 
95% and level of significance of less than 5% was determined using R (version 3.4.4) 
analytical software. 
MEPS data files are obtained using a combination of sample designs which 
include stratification, clustering, disproportionate sampling, and multiple stages of 
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selection which require special analytical considerations due to the design and estimation 
complexities of the data files (Machlin, Yu, & Zodet, 2005). As a result, MEPS data 
include sampling weights which reflect adjustments taken for both survey nonresponse 
and population control totals adjustments (Machlin, Yu, & Zodet, 2005). Additionally, 
MEPS public use data files are accompanied by estimation weight, sampling strata, and 
primary sampling unit (PSU) variables that can be used to obtain weighted estimates and 
estimate standard errors for weighted estimates through the implementation of a Taylor-
series approach (Machlin, Yu, & Zodet, 2005). Moreover, the use of R (version 3.4.4) 
statistical software is adequate in determining and estimating standard errors from 
complex multistage designs involving the Taylor-series linearization such as MEPS 
survey data. 
Threats to Validity 
The use of nationally representative self-reported survey data can result in biases 
related to recall. Since respondents to MEPS surveys also self-report data on their 
medical conditions, health care use, and health care expenditures recall bias is a threat to 
the external validity of this study and may result in differential misclassification which 
could impact the accuracy and completeness of the study data, as well as produce 
unreliable estimates (LaMorfe, 2016). A few ways in which MEPS data controls for 
recall bias involves the careful construction of the survey to maximize completeness and 
accuracy; the training of interviewers and monitoring of their performances; stimulation 
and maintenance respondent cooperation, through the use of various materials and 
strategies; the use of analytical weights to reduce nonresponse bias and improve national 
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representativeness of survey data, and to ensure the achievement of precision 
specifications; through the review of the precision of survey estimates (U.S. Department 
of Health & Human Services, 2015).  
Internal validity concerns for this study revolved around the mortality of 
participants. Respondents investigated in this study were already advanced in age, and 
possessed two chronic, and potentially debilitating health conditions. To gain a larger 
sample size to account for participant drop-out rates, the MEPS data were pooled to 
increase the sample size of the study population. Potential limitations of this study 
involve the sample size of the study population which, due to age (65 and older), is 
inherently smaller than the other survey respondents in MEPS (Safren et al., 2009). To 
account for sample size limitation, a larger population size was garnered through the 
pooling of MEPS data from 2011-2015. The content, empirical, and construct validity of 
the MEPS measuring instruments have all been adequately assessed in various research 
studies (Hayes et al., 2017; Khanna, Jariwala, & West-Strum, 2015; McCord et al., 2011; 
Montazeri et al., 2011). Additional threats to validity include other potentially 
confounding variables (i.e., healthcare access and health literacy) that were not included 
in this study’s analyses but may possibly have an impact on the generalization of the 
study results. 
Ethical Procedures 
Secondary data from the MEPS was used for data analysis for this study. The 
household component of the MEPS data was used, and no permissions were required to 
access the data because it is publicly available for use on the MEPS website as 
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downloadable data files and data tables (Williams, Bishu, Dismuke, & Egede, 2017). All 
patients interviewed by MEPS sign the medical provider component authorization form, 
which permits medical provider component staff to contact medical providers and 
pharmacies to authorize the release of medical information about their patients (AHRQ, 
2017a). While informed consent was not required from participants, because the data was 
secondary and individual identifiers were removed from the micro-data contained within 
the files (AHRQ, 2016b), AHRQ does include a data use agreement for users which 
states that efforts to determine the identity of reported cases is prohibited by law; and use 
of the data signifies compliance with data use requirements, wherein misuse is punishable 
by a fine of up to U.S. $10,000 or up to 5 years in prison (AHRQ, 2016b). AHRQ and the 
MEPS must also be cited in publications that utilize MEPS data as the source used for 
data retrieval (AHRQ, 2016b).  
Restricted MEPS data, or data that has not been released publicly due to 
confidentiality reasons, can be accessed by qualified researchers. These files consist of 
MEPS data available for the time periods 1996-1999, and 2001 (for Household 
component-insurance component linked files); and 1996 only (for Nursing home 
component files) (AHRQ, n. d.). Additional confidential files include medical provider 
component data, area resource files, MEPS public use data files, and MEPS link files to 
National Health Interview Survey (AHRQ, n. d.).  
To access restricted data, prospective researchers must submit an application, 
research proposal, and user fee of U.S. $300 (AHRQ, n. d.). All applications and 
proposals are reviewed by a committee; and approvals are based on: 1) the feasibility of 
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the existing data to the project; 2) the risk of disclosure of restricted information; 3) the 
availability of resources to support the project at the AHRQ Data Center; 4) whether the 
proposed project is in accordance with AHRQ’s mission (AHRQ, n. d.). Finally, since 
remote access to confidential data is not available, all researchers approved to access and 
use confidential data must do so using the facilities located within the AHRQ Data Center 
in Rockville, MD (AHRQ, n. d.). 
IRB approval for this study was obtained from Walden University prior to access 
and analysis of the MEPS data files. Additionally, having worked as a healthcare 
professional for over a decade with older adults, Fitzgerald and Hurst (2017) assert that 
implicit biases, which involve associations outside conscious awareness, can lead to 
negative evaluation of this cohort based on irrelevant characteristics such as race or 
gender. As a result, my goal is to remain as unbiased as I can and look solely at the data 
when performing analyses and drawing conclusions. Finally, data used in any analyses 
for this study was stored on a personal password-protected laptop under password 
protected files. 
Summary 
In this section, an overview of the quantitative inquiry methods used for this study 
was provided, as well as the justification for study design’s appropriateness. Also 
discussed within this section was the study methodology, which included the population, 
sampling procedures, instrumentation and operationalization of constructs and variables, 
and plans for data analysis. Additionally, threats to internal and external validity and 
ethical concerns associated with the study were also addressed. In the upcoming section, 
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Section 3: Presentation of the Results and Findings 
Introduction 
This section addresses the data collection, study results, and the summary of the 
study’s findings. The purpose of this quantitative study was to determine the association 
of total medical expenditures among Blacks and Whites aged 65 and older with a 
diagnosis of HIV or cardiovascular disease when compared to individuals of the same 
race with the same diagnoses aged 64 and younger. Additionally, I examined the effect 
that type of health service had on the total medical expenditures incurred for patients with 
an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease). A binary logistic regression analysis was conducted to determine whether a 
statistically significant relationship exists between the dependent variable (total medical 
expenditures) and the independent variables (age and race) as it relates to HIV or 
cardiovascular disease diagnoses, when accounting for confounding variables (e.g., 
education, insurance, and region of residence). The following are the research questions 
and hypotheses formulated for this study:  
Research Question 1: What differences in total medical expenditures exist 
between American adults aged 65 and older, and American adults aged 64 and younger 
with a diagnosis of cardiovascular disease or HIV? 
H01: There is no significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
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Ha1: There is a significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Research Question 2: What are the differences in total medical expenditures 
between Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease 
or HIV, when compared to individuals of the same race, with the same diagnoses, aged 
64 and younger? 
H02: There is no significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Ha2: There is a significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Research Question 3: What effect does type of health service (prescribed 
medicines, hospital inpatient stay, emergency room visits, office based medical provider 
visits, home health visits, and outpatient visits) utilized have on the total medical 
expenditures incurred for patients with an infectious disease (HIV) versus patients with a 
chronic disease (cardiovascular disease)? 
H03: There is no significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
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disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Ha3: There is a significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Data Collection of Secondary Data Set  
Files for each expenditure were drawn from the MEPS database over a 5-year 
period (2011–2015). The MEPS household component data files represent a nationally 
representative U.S. civilian, noninstitutionalized population and is based on 
questionnaires derived from individual household members and diverse medical provider 
sites (MEPS, 2009). This data set includes 30 individual files, with one per expenditure 
type for each year. Before these datasets could be combined, expenditures for each year 
required adjusting based on inflation. The 2011–2014 total healthcare expenditures were 
adjusted to the value of the U.S. dollar in 2015 using the consumers price index from the 
Bureau of Labor Statistics (n.d.), as reported by the AHRQ (2017c). The U.S. dollar 
value was adjusted to be equivalent to inflation in 2015 so that the sum values were not 
underrepresented and a summation of the expenditures over this time could be 
meaningful. Table 1 provides the inflation rate for each type of expenditure, which was 





Inflation for Each Year by Type 
Variable Outpatient Office-
based 




       
2011  1.05 1.09 1.13 1.07 1.03 1.07 
2012 1.04 1.07 1.09 1.04 1.02 1.04 
2013 1.02 1.04 1.08 1.02 1.02 1.02 
2014 1.01 1.02 1.05 1.01 1.01 1.01 
Note. Inflation adjusting was only performed on the years 2011 to 2014 to adjust to 2015 
levels. 
After adjusting all expenditures to the inflation for 2015, expenditures from each 
of the 5 years were summed into a single expenditure variable, with one for each of the 
dependent variables. As the weights for each participant were also necessary to include 
for external validity, weights from each year were calculated into a mean, which was 
used as the final weight for each dependent variable. Because different weights were 
associated with an individual based on their existence in one of the six datasets 
(outpatient, office-based visit, medication, inpatient, home health, emergency room), 
participants were assessed based on their demographic representation in comparison to 
their proportional representation in the dataset. Underrepresented groups in the dataset 
are given more weight so that they were represented similarly to their group’s true 
representation in the population. Likewise, overrepresented groups in the dataset are 
weighted less so that they did not influence the results.  
After extracting the mean weights, summed adjusted expenditures, and pertinent 
demographic data, each expenditure’s dataset was combined into a final dataset 
consisting of all individuals with any entry for any of the six expenditures over the 2011–
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2015 period. From this sample, any individuals who did not have either HIV or 
cardiovascular disease were excluded. In the final dataset, some of the expenditure 
variables exhibited negative values, which did not have any true monetary meaning. Such 
values were deleted because they were patient reported medical events that resulted in 
zero payment, thus the expenditure data associated with those entries was deemed 
inapplicable (MEPS, 2017). Removal of these inapplicable values allowed participants to 
be excluded from an analysis when they had a negative value without being deleted from 
the dataset entirely. This allowed participants who had useful data for at least one other 
dependent variable component to be retained for any analysis where they had complete 
data. Overall, these negative values were the only discrepancies encountered in this 
dataset. 
Normality of Dependent Variables 
Shapiro-Wilk tests were conducted to determine the degree to which normality 
was exhibited for each dependent variable. The Shapiro-Wilk test is based on the 
correlation between the corresponding normal scores and the data (Ghasemi & Zahediasl, 
2012). It compares the scores in the sample to a normally distributed set of scores with 
the same mean and standard deviation. If the sample distribution is normal, then the null 
hypothesis is supported. Conversely, if the distribution is nonnormal, the test is 
significant.  
Results could not be calculated for office-based or medical-based expenditures, as 
the sample sizes for these variables were greater than 5,000, and this is a limitation of R 
(version 3.4.4). However, skew and kurtosis values for each variable were calculated and 
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found to be outside of the range of acceptability for a normal distribution, as defined by 
skew values greater than two and kurtosis values greater than three (Westfall & Henning, 
2013). Thus, normality could not be assumed for the any of the expenditures of interest 
(see Table 2).  
Table 2 
 
Normality Assessment for Expenditure Variables 
Variable Mean SD Skew Kurtosis W P Normality 
Outpatient 
(n = 2,406) 
536.45 1,857.07 13.33 237.32 0.24 < .001 No 
Office based 
(n = 5,500) 
5,075.04 12,189.56 18.35 653.24 - - No 
Medication 
(n = 5,588) 
7,463.55 13,320.34 6.89 89.759 - - No 
Inpatient 
(n = 2,141) 
2,796.11 5,296.94 9.97 179.38 0.44 < .001 No 
Home health 
(n = 1,137) 
1,1741.33 24,399.55 10.52 191.91 0.41 < .001 No 
Emergency 
room 
(n = 2,529) 
2,161.07 4,288.93 6.39 60.11 0.45 < .001 No 
Note. Shapiro-Wilk tests are not available in R for sample sizes greater than 5,000. 
Based on the lack of normality among each of the dependent variables, wherein 
distributions were consistently right skewed (i.e., heavily shifted toward low 
expenditures), each dependent variable was transformed into a dichotomous variable, 
defined by median split so there were equally sized groups for the categories of large 
expenditure and small expenditure. Brief preliminary testing indicated that the 
expenditure variables could not contribute to valid linear regression models without 
extensive transformations, which would render the results much less interpretable 
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(Stevens, 2016) Further, the values would need to be mirrored before applying a 
transformation of  
Because accessibility and interpretability were important aspects of the study, a 
more straightforward approach was selected, and expenditure variables were modified 
into binary variables with a value of one representing an expenditure higher than the 
median and a value of zero representing an expenditure lower than or equal to the 
median. This resulted in nearly equal groups of high and low expenditures, so the odds of 
having a higher expenditure were approximately 50% for each analysis. These binary 
transformations allowed the originally proposed linear regressions to be modified to 
binary logistic regressions and circumvented the requirement of normal data (Stevens, 
2016). In doing so, each of the restrictive assumptions typically associated with linear 
regression (e.g., normality, homoscedasticity, and linearity) did not require assessment. 
This also allowed each of the regression results to be used for predictive purposes (i.e., 
predicting whether expenditures were higher or lower), in an intuitive way so odds ratios 
from the regressions could help predict whether an individual would have a higher or 
lower expenditure.  
Because the binary logistic regression is calculated using chi square statistics, 
which is sensitive to large sample sizes (i.e., tends toward significance as the sample size 
increases), it was also important to explore the effect sizes for the variables within the 
regressions (Stevens, 2016). This was done using odds ratios, which are not standardized 
and must be compared to one another to determine the strongest predictors. Thus, this 
detail must be examined in the final series of regressions, wherein all predictors are 
71 
 
included simultaneously in the finalized multivariate models. For this reason, comparison 
of effects will take place with the interpretation of the Research Question 3 results and 




Data were first sorted to only include participants with values for each dependent 
variable, as these subgroups consisted of the only observations available for each 
corresponding analysis. Descriptive statistics were calculated for each of these subgroups 
to better understand the demographic makeup for each analysis. To measure the 
significance level of the predictor variable, the Wald F test was used. In addition, means 
and standard deviations were calculated for each group’s age representation. As seen in 
Table 3, ages were similarly represented in each analysis except for the regression for 
home health expenditures, which consisted of a slightly older average representation 
within the sample. 
Table 3 
 
Mean and Standard Deviation for Age Using Sample for Each Dependent Variable 
Variable Outpatient 
(n = 2,406) 
Office 
based 
(n = 5,500) 
Medication 
(n = 5,588) 
Inpatient 
(n = 2,141) 
Home 
health 
(n = 1,137) 
Emergency 
room 
(n = 2,529) 
Age       
Mean 65.97 65.63 65.65 66.66 71.40 65.00 
SD 13.27 14.13 14.07 13.92 12.97 14.80 
 
In addition to this continuous measurement of age, age categories of 64 and 
younger versus 65 and older were examined, as these were the categories used in each 
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analysis. Together with this examination of age group membership by analysis, race, sex, 
poverty level, and HIV or cardiovascular disease cases represented in each model were 
also assessed. As it relates to the population for this study, a CDC report showed that 
between 2011 and 2015 there was an increase in the number and rate of diagnosed HIV 
infections for persons living in the United States (CDC, 2017d). The largest increase in 
HIV infection rates was found among persons aged 65 and older, at a rate of 57% (CDC, 
2017d). Male adults had higher transmission rates between 2011 and 2015 when 
compared to women, and of the 973,846 individuals living with HIV at the end of 2015, 
Blacks had the largest percentage of diagnosed HIV infection (42%) when compared to 
all other race/ethnicity groups (CDC, 2017d).  
As it pertains to cardiovascular disease, data from a report on 2011–2014 
NHANES data indicated that 92.1 million American adults have at least one type of 
cardiovascular disease, with 46.7 million estimated to be older than 60 years of age 
(Benjamin et al., 2017). The report indicated that cardiovascular disease in adults 
increases in both males and females as they get older, with the prevalence among males 
(between 2011-2014) reported at 37.4%, compared to females at 35.9% in adults aged 20 
and older (Benjamin et al., 2017). Older adults aged 60-79 were reported to have a 
prevalence of cardiovascular disease of 69.6% among men and 68.6% among women. 
The prevalence of cardiovascular disease was even higher among older adults aged 80 
years and older, with a percentage of 84.4% among men and 86.5% among women 
between 2011–2014 (Benjamin et al., 2017). Cardiovascular disease was considerably 
lower among individuals in the 20-39 and 40-59 age ranges, with 13.5% and 41.4% 
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(men) and 11.5% and 39.4% (female) cardiovascular disease prevalence being reported 
for those age ranges, respectively (Benjamin et al., 2017). The prevalence of 
cardiovascular disease among non-Hispanic Whites was reported at 37.7% (males) and 
35.1% (females), whereas among Blacks, the prevalence of cardiovascular disease was 
46.0% (males) and 47.7% (females) among adults aged 20 and older between 2011 and 
2014 (Benjamin et al., 2017). Further, the prevalence of heart disease was found to be 
higher among individuals with who were unemployed and had lower education 
(Benjamin et al., 2017). 
The sample used for this analysis was focused only on individuals with either an 
HIV or cardiovascular disease diagnosis. Due to the narrow characteristics of the 
participants in this study, the results cannot be generalized to individuals without these 
diagnoses within the larger population (Creswell, 2009). The demographic data analyzed 
for this study, particularly the insurance, education, and region of residence variables, 
showed that well-over half of the study population were Medicare recipients, over one-
third were from the southern states in the United States, and roughly two-thirds of 
participants had at least a high school and/or a college education. Frequencies and 
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Note. Percentages are based on valid percent and calculated based on the total responses. 
Not all observations had corresponding data for each demographic variable. Percentages 
may not sum to 100 due to rounding. 
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Descriptive statistics were calculated to understand the mean of each expenditure 
based on each category of insurance type, education, and region of residence. These 
means were based on the total inflation adjusted expenditure from 2011 to 2015. Though 
these were not of direct interest based on the research questions, information gleaned 
from the examination of these group means helps to frame the study and may provide 
insight to future researchers studying this topic. However, because these figures are based 
on descriptive statistics only, they are not weighted, and no statistical inferences are 
intended to be drawn from this information. This information is presented in Table 5. 
Table 5 
 
Means and Standard Deviations for Expenditures for Each Demographic Category of 
Household-Reported Medical Events 
 
Demographic Outpatient 
(n = 2,406) 
Office 
based 
(n = 5,500) 
Medication 
(n = 5,588) 
Inpatient  
(n = 2,141) 
Home health 
(n = 1,137) 
Emergency 
room 
(n = 2,529) 



























































































































































































Note. Values indicate means, parenthetical values indicate standard deviations. 
Research Question 1 
Research Question 1: What differences in total medical expenditures exist 
between American adults aged 65 and older, and American adults aged 64 and younger 
with a diagnosis of cardiovascular disease or HIV? 
H01: There is no significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Ha1: There is a significant difference in total medical expenditures between 
American adults aged 65 and older and American adults aged 64 and younger with a 
diagnosis of cardiovascular disease or HIV. 
Analyses for Research Question 1 centered on the specific difference between the 
two age groups of interest and were conducted as two-way analyses following a binary 
logistic regression model with the dichotomous expenditure variable (i.e., high versus 
low expenditure) used as the criterion in each regression. Though the binary logistic 
regression does not share the same restrictive assumptions as a linear regression, and 
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therefore does not require that the assumptions of normality, homoscedasticity, or 
linearity be met, each analysis was assessed to ensure that each had an adequate sample 
size (i.e., N > 200; see Stevens, 2016), and enough representation in each group of the 
dependent variable. The sample size for each was sufficient for the binary logistic 
regressions in each analysis, and group representation was equal for each dependent 
variable based on the method of dichotomization, which resulted in near-equally sized 
groups. In each analysis, there was one predictor variable, which was entered as the 
binary age variable (i.e., 64 and below versus 65 and above). Results of each analysis 
indicate whether likelihood of placement into the high expenditure group is dependent on 
age group placement (i.e., 64 and younger versus 65 and older). It was important to 
determine whether each binary logistic regression model was significant before 
interpreting the results; this was accomplished by examining the chi square statistic, 
which is the test statistic resulting from binary logistic regression and indicates the 
significance of the overall model (Stevens, 2016). Because the sample was weighted to 
represent the entirety of the US population of interest, the analytical power was very 
high, and estimates for the regression outputs, such as odds ratios, were extremely close 
to their confidence intervals, in many cases appearing identical unless examined at three 
decimal places. This was evidence for a high level of certainty that the estimates resulting 
from the binary logistic regressions were realistic representations of the population. 
Outpatient Expenditures 
Results of the binary logistic regression of outpatient expenditures on age were 
significant, χ2(1) = 2,409.30, p < .001. These findings indicated that those aged 65 and 
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older had a significantly different outpatient expenditure than their 64 and younger 
counterparts. Examination of odds ratios and estimates revealed that there was a positive 
association, such that, participants aged 65 and older had significantly higher odds of 
incurring higher outpatient expenditures. Based on the odds ratio, there were 1.04 times 
higher odds of having a higher outpatient expenditure among the older group when 
compared to the 64 and younger group, and the null hypothesis was rejected. Because the 
data were grouped such that the baseline odds of a higher expenditure was 50%, the odds 
ratio of 1.040 means that patients aged 65 and over had only 2% higher odds of incurring 
a higher outpatient expenditure (i.e., odds of 52%), meaning that age may not change the 
risk to a meaningful extent. Table 6 provides the results of this analysis as broken down 
based on the individual predictor. Estimates of the intercept were calculated for each 
logistic regression to create probability equations, though the odds ratio and significance 
of the intercept are irrelevant to the goals of this study and were not included. The 





Binary Logistic Regression of Outpatient Expenditures on Age 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Age: 65 and older 
(ref: 64 and younger) 





Results of the binary logistic regression of office-based expenditures on age were 
significant, χ2(1) = 273,284.01, p < .001. These findings indicated that those aged 65 and 
older had a significantly different office-based expenditure than their 64 and younger 
counterparts. Examination of odds ratios and estimates revealed that there was a positive 
association such that participants aged 65 and older had significantly higher odds of 
incurring higher office-based expenditures. Based on the odds ratio, there were 1.33 
times higher odds of having a higher office-based expenditure among the older group 
when compared to the 64 and younger group, and the null hypothesis was rejected. 
Because the data were grouped such that the baseline odds of a higher expenditure was 
50%, the odds ratio of 1.328 means that patients aged 65 and over had 16.5% higher odds 
of incurring a higher expenditure (i.e., odds of 66.5%), meaning that age changed the risk 
of higher office-based expenditures to a meaningful extent. Table 7 provides the results 
of this analysis as broken down based on the individual predictor. The resulting 




Binary Logistic Regression of Office-Based Expenditures on Age 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Age: 65 and older 
(ref: 64 and younger) 





Results of the binary logistic regression of medication expenditures on age were 
significant, χ2(1) = 999.62, p < .001. These findings indicated that those aged 65 and 
older had a significantly different medication expenditure than their 64 and younger 
counterparts. Examination of odds ratios and estimates revealed that there was a positive 
association such that participants aged 65 and older had significantly higher odds of 
incurring higher medication expenditures. Based on the odds ratio, there were 1.02 times 
higher odds of having a higher medication expenditure among the older group when 
compared to the 64 and younger group, and the null hypothesis was rejected. Because the 
data were grouped such that the baseline odds of a higher expenditure was 50%, the odds 
ratio of 1.017 means that patients aged 65 and over had only 1% higher odds of incurring 
a higher medication-based expenditure (i.e., odds of 51%), meaning that age may not 
change the risk to a meaningful extent. Table 8 provides the results of this analysis as 





Binary Logistic Regression of Medication Expenditures on Age 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Age: 65 and older 
(ref: 64 and younger) 





Results of the binary logistic regression of inpatient expenditures on age were 
significant, χ2(1) = 8670.40, p < .001. These findings indicated that those aged 65 and 
older had a significantly different inpatient expenditure than their 64 and younger 
counterparts. Examination of odds ratios and estimates revealed that there was a positive 
association such that participants aged 65 and older had significantly higher odds of 
incurring higher inpatient expenditures. Based on the odds ratio, there was 1.08 times 
higher odds of having a higher inpatient expenditure among the older group when 
compared to the 64 and younger group, and the null hypothesis was rejected. Because the 
data were grouped such that the baseline odds of a higher expenditure was 50%, the odds 
ratio of 1.085 means that patients aged 65 and over had only 4% higher odds of incurring 
a higher inpatient expenditure (i.e., odds of 54%), meaning that age may not change the 
risk to a meaningful extent. Table 9 provides the results of this analysis as broken down 




Binary Logistic Regression of Inpatient Expenditures on Age 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Age: 65 and older 
(ref: 64 and younger) 




Home Health Expenditures 
Results of the binary logistic regression of home health expenditures on age were 
significant, χ2(1) = 101,767.02, p < .001. These findings indicated that those aged 65 and 
older had a significantly higher home health expenditure than their 64 and younger 
counterparts. Examination of odds ratios and estimates revealed that there was a positive 
association such that participants aged 65 and older had significantly higher odds of 
incurring higher home health expenditures. Based on the odds ratio, there was 1.58 times 
higher odds of having a higher home health expenditure among the older group when 
compared to the 64 and younger group, and the null hypothesis was rejected. Because the 
data were grouped such that the baseline odds of a higher expenditure was 50%, the odds 
ratio of 1.580 means that patients aged 65 and over had 29% higher odds of incurring a 
higher expenditure (i.e., odds of 79%), meaning that age changed the risk of higher home 
health expenditures to a meaningful extent. Table 10 provides the results of this analysis 





Binary Logistic Regression of Home Health Expenditures on Age 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Age: 65 and older 
(ref: 64 and younger) 




Emergency Room Expenditures 
Results of the binary logistic regression of emergency room expenditures on age 
were significant, χ2(1) = 111,301.00, p < .001. These findings indicated that those aged 
65 and older had a significantly different emergency room expenditure than their 64 and 
younger counterparts. Examination of odds ratios and estimates revealed that there was a 
negative association such that participants aged 65 and older had significantly lower odds 
of having higher emergency room expenditures. Based on the odds ratio, there were 0.76 
times the odds of having a higher emergency room expenditure among the older group 
when compared to the 64 and younger group, and the null hypothesis was rejected. 
Because the data were grouped such that the baseline odds of a higher expenditure was 
50%, the odds ratio of 0.764 means that patients aged 65 and over had 12% higher odds 
of incurring a higher expenditure (i.e., odds of 38%), meaning that age changed the risk 
of higher emergency room expenditures to a meaningful extent. Table 11 provides the 
results of this analysis as broken down based on the individual predictor. The resulting 




Binary Logistic Regression of Emergency Room Expenditures on Age 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Age: 65 and older 
(ref: 64 and younger) 




Research Question 2 
Research Question 2: What are the differences in total medical expenditures 
between Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease 
or HIV, when compared to individuals of the same race, with the same diagnoses, aged 
64 and younger? 
H02: There is no significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Ha2: There is a significant difference in total medical expenditures between 
Blacks and Whites aged 65 and older with a diagnosis of cardiovascular disease or HIV, 
when compared to individuals of the same race, with the same diagnoses, aged 64 and 
younger. 
Analyses for Research Question 2 centered on the specific difference between the 
two age/race groups of interest (i.e., White versus Black and age 65 and older versus age 
64 and younger) and were conducted as two-way analyses following a binary logistic 
regression model with the dichotomous expenditure variable (i.e., high versus low 
expenditure) used as the criterion in each regression. In each analysis, there was one 
predictor variable, which was entered as the categorical race variable (i.e., Black, White, 
and Other), and dummy coded with “other” acting as the reference category such that 
specific findings for the Black and White groups could be compared to one another. 
Results of each analysis indicate whether likelihood of placement into the high 
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expenditure group is dependent on race. One such analysis was conducted for each 
dependent variable. Because the sample was weighted to represent the entirety of the U.S. 
population of interest, the analytical power was very high, and estimates for the 
regression outputs, such as odds ratios, were extremely close to their confidence 
intervals, in many cases appearing identical unless examined at three decimal places. This 
was evidence for a high level of certainty that the estimates resulting from the binary 
logistic regressions were realistic representations of the population. 
Outpatient Expenditures 
Results of the binary logistic regression of outpatient expenditures on race were 
significant, χ2(2) = 50,133.02, p < .001, resulting in a rejection of the null hypothesis. 
These findings indicated that both White and Black participants had a significantly 
different outpatient expenditures when compared to the group of participants who were 
any other race (denotes other non-white races i.e., Asian, Native America, Native 
Hawaiian, multiple races etc., and referenced as other, henceforth). Examination of odds 
ratios and estimates revealed that, while both race groups were significantly different 
from the other category, the White group of participants saw higher odds of being in the 
high expenditure group than their Black or other counterparts. Based on the odds ratio, 
there were 1.451 times higher odds (i.e., odds of 72.5%) of having a higher outpatient 
expenditure among the White group; while among the Black group there were 1.258 
times higher odds (i.e., odds of 63%) of having a higher outpatient expenditure when 
compared to the others. As these odds represent a 22.5% and 13% increase in likelihood 
of higher outpatient expenditures respectively, both race-related findings present 
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meaningful results. Table 12 provides the results of this analysis as broken down based 






Binary Logistic Regression of Outpatient Expenditures on Race 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Race: Black (ref: other) 0.22 0.00 1.258 [1.252, 1.263] 105.50 < .001 
Race: White (ref: other) 0.37 0.00 1.451 [1.446, 1.457] 201.00 < .001 
 
Office-Based Expenditures 
Results of the binary logistic regression of office-based expenditures on race were 
significant, χ2(2) = 372,747.20, p < .001, resulting in a rejection of the null hypothesis. 
These findings indicated that both White and Black participants had a significantly 
different office-based expenditures when compared to the group of participants who were 
any other race. Examination of odds ratios and estimates revealed that, while both race 
groups were significantly different from the other category, the White group of 
participants saw higher odds of being in the high office-based expenditure group than 
their Black or other counterparts. Based on the odds ratio, there was 1.43 times higher 
odds (i.e., odds of 71.5%) of having a higher office-based expenditure among the White 
group; while among the Black group there were 0.91 times the odds of having a higher 
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office-based expenditure (i.e., odds of 45.5%), when compared to the others. As these 
odds represent a 21.5% increase and 4.5% decrease in likelihood of higher office-based 
expenditures respectively, these race-related findings present meaningful results. Table 
13 provides the results of this analysis as broken down based on the individual predictor. 




Binary Logistic Regression of Office-Based Expenditures on Race 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Race: Black (ref: other) -0.10 0.00 0.906  [0.904, 0.909] -71.09 < .001 
Race: White (ref: other) 0.36 0.00 1.433  [1.429, 1.436] 303.15 < .001 
.  
Medication Expenditures 
Results of the binary logistic regression of medication expenditures on race were 
significant, χ2(2) = 36,178.20, p < .001, resulting in a rejection of the null hypothesis. 
These findings indicated that both White and Black participants had a significantly 
different medication expenditures when compared to the group of participants who were 
any other race. Examination of odds ratios and estimates revealed that, while both race 
groups were significantly different from the other category, both White and Black groups 
were similarly likely to have a high expenditure. Based on the odds ratio, there was 1.251 
times higher odds of having a higher medication expenditure among the White group 
(i.e., odds of 63%); while among the Black group there was 1.241 times higher odds (i.e., 
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odds of 62.1%) of having a higher medication expenditure when compared to the others. 
As these odds represent a 13% and 12.1% increase in likelihood of higher outpatient 
expenditures respectively, both race-related findings present meaningful results. Table 14 
provides the results of this analysis as broken down based on the individual predictor. 




Binary Logistic Regression of Medication Expenditures on Race 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Race: Black (ref: other) 0.22 0.00 1.241  [1.238, 1.244] 156.70 < .001 
Race: White (ref: other) 0.22 0.00 1.251  [1.248, 1.254] 189.60 < .001 
 
Inpatient Expenditures 
Results of the binary logistic regression of inpatient expenditures on race were 
significant, χ2(2) = 35,966.01, p < .001, resulting in a rejection of the null hypothesis. 
These findings indicated that both White and Black participants had significantly 
different inpatient expenditures when compared to the group of participants who were 
any other race. Examination of odds ratios and estimates revealed that, while both race 
groups were significantly different from the other category, the White group of 
participants had higher odds of incurring higher inpatient expenditures than their Black or 
other counterparts. Based on the odds ratio, there was 1.245 times higher odds of having 
a higher inpatient expenditure among the White group (i.e., odds of 62%); while among 
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the Black group there was 1.007 times higher odds (i.e., odds of 50.5%) of having a 
higher inpatient expenditure, when compared to the others. As these odds represent a 
12% increase in likelihood of higher inpatient expenditures in the White group, the race-
related findings present meaningful results. However, results for the Black group may not 
be as meaningful, and only change the likelihood of higher expenditures by 0.5%. Table 
15 provides the results of this analysis as broken down based on the individual predictor. 




Binary Logistic Regression of Inpatient Expenditures on Race 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Race: Black (ref: other) 0.01 0.00 1.007 [1.002, 1.012] 2.99  .003 
Race: White (ref: other) 0.22 0.00 1.245 [1.239, 1.250] 103.39 < .001 
 
Home Health Expenditures 
Results of the binary logistic regression of home health expenditures on race were 
significant, χ2(2) = 81,055.22, p < .001, resulting in a rejection of the null hypothesis. 
These findings indicated that both White and Black participants had significantly 
different home health expenditures when compared to the group of participants who were 
any other race. Examination of odds ratios and estimates revealed that, while both race 
groups were significantly different from the other category, the Black group of 
participants had higher odds of being in the high home health expenditure group than 
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their White or other counterparts. Based on the odds ratio, there was 1.071 times higher 
odds (i.e., odds of 53.5%) of having a higher home health expenditure among the Black 
group; while among the White group there was 0.675 times the odds (i.e., odds of 33.5%) 
of having a higher home health expenditure, when compared to the others. As these odds 
represent a 16.5% decrease in likelihood of higher home health expenditures within the 
White group, these race-related findings present meaningful results. Table 16 provides 
the results of this analysis as broken down based on the individual predictor. The 




Binary Logistic Regression of Home Health Expenditures on Race 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Race: Black (ref: other) 0.07 0.00 1.071 [1.064, 1.078] 21.37 < .001 
Race: White (ref: other) -0.39 0.00 0.675 [0.671, 0.679] -139.33 < .001 
 
Emergency Room Expenditures 
Results of the binary logistic regression of emergency room expenditures on race 
were significant, χ2(2) = 13,663.22, p < .001, resulting in a rejection of the null 
hypothesis. These findings indicated that both White and Black participants had 
significantly different emergency room expenditures when compared to the group of 
participants who were any other race. Examination of odds ratios and estimates revealed 
that, while both race groups were significantly different from the other category, the 
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White group of participants had higher odds of incurring higher emergency room 
expenditures than their Black or other counterparts. Based on the odds ratio, there was 
1.124 times higher odds (i.e., odds of 56%) of having a higher emergency room 
expenditure among the White group; while among the Black group there was 0.996 times 
the odds (i.e., odds of 49.5%) of having a higher emergency room expenditure, when 
compared to the others. As these odds represent a 6% increase and 0.5% decrease in 
likelihood of higher outpatient expenditures respectively, race-related findings were not 
meaningful to the likelihood of higher emergency room expenditures. The resulting 




Binary Logistic Regression of Emergency Room Expenditures on Race 
   Odds ratio   
Source Estimate SE OR 95% CI Wald P 
       
Race: Black (ref: other) -0.01 0.00 0.996 [0.991, 1.000] -2.06 .040 
Race: White (ref: other) 0.11 0.00 1.124 [1.120, 1.129] 61.23 < .001 
 
Research Question Three 
Research Question 3: What effect does type of health service (prescribed 
medicines, hospital inpatient stay, emergency room visits, office based medical provider 
visits, home health visits, and outpatient visits) utilized have on the total medical 
expenditures incurred for patients with an infectious disease (HIV) versus patients with a 
chronic disease (cardiovascular disease)? 
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H03: There is no significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Ha3: There is a significant difference in total medical expenditures for patients 
with an infectious disease (HIV) versus patients with a chronic disease (cardiovascular 
disease) when different types of health services (prescribed medicines, hospital inpatient 
stay, emergency room visits, office based medical provider visits, home health visits, and 
outpatient visits) are used. 
Analyses for Research Question 3 centered on the influence of placement in the 
HIV or cardiovascular disease groups and were conducted as multivariate analyses 
following a binary logistic regression model with the dichotomous expenditure variable 
(i.e., high versus low expenditure) used as the criterion in each regression. These analyses 
not only consider the findings from the previous regressions (i.e., that race and age are 
related to expenditure), but also control for age and race when testing for the effect of 
either diagnosis. In addition, sex and poverty level are included in these analyses as 
control variables.  
In each analysis, there is one predictor variable for each diagnosis where possible, 
although some analyses could not run while testing both cardiovascular disease and HIV 
for their influence. This is due to the small representation of patients with HIV but 
without cardiovascular disease, which were too sparse and limited the outpatient, office-
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based, medication, and inpatient expenditure models such that they could not converge. 
These models were revised to exclude the effect of cardiovascular disease or HIV from 
the model, depending on which allowed the model to converge. Results of each analysis 
indicate whether likelihood of placement into the high expenditure group is dependent on 
incidence of HIV or cardiovascular disease, as well as race, sex, poverty level, and age. 
One such analysis was conducted for each dependent variable. Examination of 
effects within the models were also conducted using odds ratios, which are not 
standardized, and thus must be compared to one another to determine the strongest 
predictors. It is important to note that because the sample was weighted to represent the 
entirety of the US population of interest, the analytical power was very high, and 
estimates for the regression outputs, such as odds ratios, were extremely close to their 
confidence intervals, in many cases appearing identical unless examined at three decimal 
places. This was evidence for a high level of certainty that the estimates resulting from 
the binary logistic regressions were realistic representations of the population. This 
method of understanding the strongest predictors in each model was carried out in 
response to the large sample size, which drove the results towards significance. For this 
reason, it was important to understand not only which predictor variables were 
significant, but which were most closely related to each expenditure. 
Outpatient Expenditures 
The first attempt at creating a multivariate binary logistic regression model 
inclusive of age, sex, race, poverty level, HIV status, and cardiovascular disease status 
did not converge. After assessing representation of each variable in the analysis, it was 
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determined that there was a low number of participants with HIV, wherein an 
overwhelming majority did not have HIV, which restricted the model’s ability to 
converge. By removing this variable from the model, the regression no longer had to fit 
HIV data to the outcome and was therefore able to converge. This analysis still provided 
insight into the relationship between cardiovascular disease and expenditures, and still 
included participants who were HIV positive. 
Results for the regression of outpatient expenditures on cardiovascular disease 
status, race, age, sex, and poverty level were significant, χ2(6) = 303,487.62, p < .001. 
Based on the evidence for overall significance in the model, the model’s predictors were 
examined individually to determine which variables were significantly predictive, as well 
as the nature of any identified relationships. Each of the variables in the model were 
significant, though the focus of Research Question 3 pertains to the influence of a 
cardiovascular disease or HIV diagnosis on expenditures. As the HIV variable could not 
be included in this analysis without causing problems with convergence, the focus of 
interpretation in this analysis was the effect of a cardiovascular disease diagnosis. While 
it is noteworthy that men tended to have 0.700 times the odds of having a high outpatient 
expenditure, and among poor to low income participants there were 0.81 times the odds 
of having high outpatient expenditures, examination of the cardiovascular disease trait 
was of direct importance to the research question. Interpretation of the estimate and odds 
ratio indicated a positive relationship, where those with cardiovascular disease had higher 
odds of incurring high outpatient expenditures, which resulted in a rejection of the null 
hypothesis. Based on the odds ratio, there was 1.235 times the odds of higher outpatient 
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expenditures among those with cardiovascular disease when compared to their 
counterparts without cardiovascular disease. Race had the strongest predictive ability in 
the model, with the White category showing an odds ratio of 1.400 (i.e., 70% likelihood). 
Based on the 20% increase in likelihood of higher outpatient expenditures, this predictor 
was most influential in the prediction of outpatient expenditures. Table 18 provides the 




Binary Logistic Regression of Outpatient Expenditures on Race, Age, and Covariates 
   Odds ratio   
Source Estimate SE OR 95% CI Wald p 
       
Race: Black (ref: other) 0.18 0.00 1.205 [1.200, 1.210] 85.22 < .001 
Race: White (ref: other) 0.33 0.00 1.400 [1.395, 1.405] 179.71 < .001 
Age: 65 and older (ref: < 64) 0.01 0.00 1.008 [1.006, 1.010] 9.56 < .001 
Sex: Male (ref: female) -0.35 0.00 0.700 [0.699, 0.701] -448.05 < .001 
Poverty: Poor or low  
(ref: medium or high) 
-0.21 0.00 0.807  [0.806, 0.809] -262.57 < .001 
Cardiovascular disease 0.22 0.00 1.235  [1.227, 1.243] 63.72 < .001 
 
Office-Based Expenditures 
The first attempt at creating a multivariate binary logistic regression model 
inclusive of age, sex, race, poverty level, HIV status, and cardiovascular disease status 
did not converge. After assessing representation of each variable in the analysis, it was 
determined that the low number of participants with HIV, wherein an overwhelming 
majority did not have HIV, restricted the model’s ability to converge. By removing this 
variable from the model, the regression no longer had to fit HIV data to the outcome and 
97 
 
was able to converge. This analysis still provided insight into the relationship between 
cardiovascular disease and expenditures, and still included participants who were HIV 
positive. 
Results for the regression of office-based expenditures on cardiovascular disease 
status, race, age, sex, and poverty level were significant, χ2(6) = 855,818.22, p < .001. 
Based on the evidence for overall significance in the model, the model’s predictors were 
examined individually to determine which variables were significantly predictive, as well 
as the nature of any identified relationships. As seen in Table 19, each of the variables in 
the model were significant, though the focus of Research Question 3 pertains to the 
influence of a cardiovascular disease or HIV diagnosis on expenditures. As the HIV 
variable could not be included in this analysis without causing problems with 
convergence, the focus of interpretation in this analysis was the effect of a cardiovascular 
disease diagnosis. While it is noteworthy that men tended to have 0.877 times the odds of 
having a high office-based expenditure, and poor to low income participants had 0.755 
times the odds of a high office-based expenditure, examination of the cardiovascular 
disease trait was of direct importance to the research question. Interpretation of the 
estimate and odds ratio indicated a negative relationship, where those with cardiovascular 
disease had lower odds of having high office-based expenditures and resulted in a 
rejection of the null hypothesis. Based on the odds ratio, those with cardiovascular 
disease tended to have 0.858 times the odds of a higher expenditure than their 
counterparts without cardiovascular disease on office-based expenditures. Race had the 
strongest predictive ability in the model, with the White category showing an odds ratio 
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of 1.352 (i.e., odds of 67.5%). Based on the increase of 17.5% in terms of likelihood to 
have a higher expenditure, this predictor was most influential in the prediction of office-





Binary Logistic Regression of Office-Based Expenditures on Race, Age, and Covariates 
   Odds ratio   
Source Estimate SE OR 95% CI Wald p 
       
Race: Black (ref: other) -0.09 0.00 0.912 [0.909, 0.914] -66.02 < .001 
Race: White (ref: other) 0.30 0.00 1.352 [1.349, 1.355] 252.18 < .001 
Age: 65 and older (ref: < 64) 0.24 0.00 1.271     [1.270, 1.273] 430.18 < .001 
Sex: Male (ref: female) -0.13 0.00 0.877 [0.876, 0.878] -239.39 < .001 
Poverty: Poor or low  
(ref: medium or high) 
-0.28 0.00 0.755 [0.754, 0.756] -506.53 < .001 
Cardiovascular disease -0.15 0.00 0.858 [0.854, 0.861] -75.86 < .001 
 
Medication Expenditures 
The first attempt at creating a multivariate binary logistic regression model 
inclusive of age, sex, race, poverty level, HIV status, and cardiovascular disease status 
did not converge. After assessing representation of each variable in the analysis, it was 
determined that the low number of participants with HIV may have been restricting the 
model’s ability to converge. Upon removing this variable from the model, the regression 
converged, but could not return results for the influence of HIV on the model’s predictive 
ability. As a potential amelioration, the HIV variable was reincorporated, and the 
cardiovascular disease variable was removed. Without the cardiovascular disease 
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variable, the regression was still able to converge but did not return values for this 
variable either. Thus, while the model could provide insight into the multivariate 
relationships within the model, definitive claims regarding the influence of HIV or 
cardiovascular disease on medication expenditures could not be determined. 
Considering this limitation for the analysis of medication expenditures, results for 
the regression of inpatient expenditures on HIV status, race, age, sex, and poverty level 
were significant, χ2(6) = -4,740,519.00, p < .001. Based on the evidence for overall 
significance in the model, the model’s predictors were examined individually to 
determine which variables were significantly predictive, as well as the nature of any 
identified relationships. As seen in Table 20, each of the variables in the model were 
significant, though the focus of Research Question 3 pertains to the influence of a 
cardiovascular disease or HIV diagnosis on expenditures. As the cardiovascular disease 
variable could not be included in this analysis without causing problems with 
convergence, the focus of interpretation in this analysis was the effect of an HIV 
diagnosis. 
While it is noteworthy that men tended to have 0.903 times the odds of a high 
medication expenditure, and poor to low income participants had 0.990 times the odds of 
a high medication expenditure, examination of the HIV trait was of direct importance to 
the research question. Interpretation of the estimate and odds ratio should be taken with 
caution, as the results returned infinities for the odds ratio estimate, and could not result 
in a clear rejection or acceptance of the null hypothesis for medication expenditures. The 
results, however, did provide some evidence for a positive estimate, and thus indicated a 
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positive relationship, where those with HIV had higher odds of incurring high medication 
expenditures. Race had the strongest predictive ability in the model, with the White 
category showing an odds ratio of 1.258 (i.e., odds of 63%). Based on the increase of 
13% in likelihood to have a higher expenditure, this predictor was most influential in the 




Binary Logistic Regression of Medication Expenditures on Race, Age, and Covariates 
   Odds ratio   
Source Estimate SE OR 95% CI Wald p 
       
Race: Black (ref: other) 0.14 0.00 1.149  [1.146, 1.152] -
184.50 
< .001 
Race: White (ref: other) 0.23 0.00 1.258  [1.255, 1.261] 98.36 < .001 
Age: 65 and older (ref: < 64) 0.96 0.00 1.100  [1.099, 1.101] 172.70 < .001 
Sex: Male (ref: female) -0.10 0.00 0.903  [0.902, 0.904] -
188.10 
< .001 
Poverty: Poor or low (ref: 
medium or high) 
-0.01 0.00 0.990  [0.989, 0.991] -17.78 < .001 
HIV 3.54E15 0.00 Inf.   [Inf., Inf.] 5.99E10 < .001 
 
Inpatient Expenditures 
The first attempt at creating a multivariate binary logistic regression model 
inclusive of age, sex, race, poverty level, HIV status, and cardiovascular disease status 
did not converge. After assessing representation of each variable in the analysis, it was 
determined that the low number of participants with HIV, wherein an overwhelming 
majority did not have HIV, restricted the model’s ability to converge. By removing this 
variable from the model, the regression no longer had to fit HIV data to the outcome and 
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was able to converge. This analysis still provided insight into the relationship between 
cardiovascular disease and expenditures, and still included participants who were HIV 
positive. 
Results for the regression of inpatient expenditures on cardiovascular disease 
status, race, age, sex, and poverty level were significant, χ2(6) = 188,214.22, p < .001. 
Based on the evidence for overall significance in the model, the model’s predictors were 
examined individually to determine which variables were significantly predictive, as well 
as the nature of any identified relationships. As seen in Table 21, each of the variables in 
the model were significant, though the focus of Research Question 3 pertains to the 
influence of a cardiovascular disease or HIV diagnosis on expenditures. As the HIV 
variable could not be included in this analysis without causing problems with 
convergence, the focus of interpretation in this analysis was the effect of a cardiovascular 
disease diagnosis. 
While it is noteworthy that men tended to have 1.349 times higher odds of having 
a high inpatient expenditure, and poor to low income participants had 1.027 times higher 
odds of having high inpatient expenditures, examination of the cardiovascular disease 
trait was of direct importance to the research question. Interpretation of the estimate and 
odds ratio indicated a positive relationship, where those with cardiovascular disease had 
higher odds of having high inpatient expenditures and resulted in a rejection of the null 
hypothesis. Based on the odds ratio, those with cardiovascular disease tended to have 
2.142 times higher odds (i.e., theoretically 100% likelihood) of spending more than their 
counterparts without cardiovascular disease. Based on this detail, cardiovascular disease 
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status was found to have the strongest predictive ability in the model. Based on the 
influence of cardiovascular disease in this model, which indicated that theoretically, all 
patients with cardiovascular disease would have higher expenditures, this predictor was 
most influential in the prediction of inpatient expenditures. The resulting regression 





Binary Logistic Regression of Inpatient Expenditures on Race, Age, and Covariates 
   Odds ratio   
Source Estimate SE OR 95% CI Wald p 
       
Race: Black (ref: other) 0.06 0.00 1.058 [1.053, 1.063] 23.45 < .001 
Race: White (ref: other) 0.21 0.00 1.230 [1.225, 1.235] 97.00 < .001 
Age: 65 and older (ref: < 64) 0.05 0.00 1.053 [1.052, 1.055] 57.98 < .001 
Sex: Male (ref: female) 0.30 0.00 1.349 [1.347, 1.351] 438.36 < .001 
Poverty: Poor or low (ref: 
medium or high) 
0.03 0.00 1.027 [1.025, 1.029] 30.89 < .001 
Cardiovascular disease 0.76 0.00 2.142 [2.124, 2.161] 173.45 < .001 
 
Home Health Expenditures 
The regression for home health expenditures did not encounter any issues with 
convergence, and all variables were retained. Results for the regression of home health 
expenditures on cardiovascular disease status, HIV status, race, age, sex, and poverty 
level were significant, χ2(7) = 554,553.32, p < .001. Based on the evidence for overall 
significance in the model, the model’s predictors were examined individually to 
determine which variables were significantly predictive, as well as the nature of any 
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identified relationships. As seen in Table 22, each of the variables in the model were 
significant, though the focus of Research Question 3 pertains to the cardiovascular 
disease and HIV variables, both of which were available for interpretation based on their 
inclusion in the model. While it is noteworthy that men tended to have 0.769 times the 
odds of having a high home health expenditure, and poor to low income participants had 
1.789 times higher odds of having high home health expenditures, examination of the 
cardiovascular disease and HIV traits were of direct importance to the research question.  
Interpretation of the estimates and odds ratios indicated a negative relationship 
between cardiovascular disease and home health expenditures, where those with 
cardiovascular disease had lower odds of having high home health expenditures. Based 
on the odds ratio, those with cardiovascular disease tended to have 0.753 times the odds 
of spending more than their counterparts without cardiovascular disease. Conversely, 
those with HIV had 1.850 times higher odds of incurring higher expenditures than those 
without HIV. These findings resulted in a rejection of the null hypothesis. Age had the 
strongest predictive ability in the model, showing an odds ratio of 1.926 (i.e., odds of 
96.3%). Based on these results, which indicated that nearly all patients over 65 would 
have a higher expenditure, this predictor was most influential in the prediction of home 
health expenditures. It was also found that HIV status was similarly predictive of home 
health expenditures, indicating that this was also a noteworthy predictor, and represented 
an increased odd of higher expenditures of 42.5% (i.e., odds of 92.5%) among HIV 







Binary Logistic Regression of Home Health Expenditures on Race, Age, and Covariates 
   Odds ratio   
Source Estimate SE OR 95% CI Wald p 
       
Race: Black (ref: other) -0.03 0.00 0.975   [0.968, 0.981] -7.76 < .001 
Race: White (ref: other) -0.50 0.00 0.605   [0.601, 0.608] -171.84 < .001 
Age: 65 and older (ref: < 64) 0.66 0.00 1.926   [1.920, 1.932] 421/68 < .001 
Sex: Male (ref: female) -0.25 0.00 0.769 [0.767, 0.771] -212.43 < .001 
Poverty: Poor or low (ref: 
medium or high) 
0.58 0.00 1.789 [1.785, 1.793] 470.76 < .001 
HIV 0.61 0.00 1.850 [1.819, 1.882] 71.31 < .001 
Cardiovascular disease -0.28 0.00 0.753 [0.738, 0.769] -26.81 < .001 
 
Emergency Room Expenditures 
The regression for emergency room expenditures did not encounter any issues 
with convergence, and all variables were retained. Results for the regression of 
emergency room expenditures on cardiovascular disease status, HIV status, race, age, 
sex, and poverty level were significant, χ2(7) = 235,726.22, p < .001. Based on the 
evidence for overall significance in the model, the model’s predictors were examined 
individually to determine which variables were significantly predictive, as well as the 
nature of any identified relationships. As seen in Table 23, each of the variables in the 
model were significant, though the focus of Research Question 3 pertains to the 
cardiovascular disease and HIV variables, both of which were available for interpretation 
based on their inclusion in the model. While it is noteworthy that men tended to have 
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0.899 times the odds of having a high emergency room expenditure, and poor to low 
income participants had 0.827 times the odds of having high emergency room 
expenditures, examination of the cardiovascular disease and HIV traits was of direct 
importance to the research question.  
Interpretation of the estimates and odds ratios indicated a positive relationship 
between cardiovascular disease and emergency room expenditures, where those with 
cardiovascular disease had higher odds of incurring high emergency room expenditures. 
Based on the odds ratio, those with cardiovascular disease tended to have 1.063 times 
higher odds of spending more than their counterparts without cardiovascular disease. 
Conversely, those with HIV had 0.653 times the odds of incurring higher emergency 
room expenditures than those without HIV. These findings resulted in a rejection of the 
null hypothesis. Based on the odds ratio, HIV status had the strongest predictive ability in 
the model. Based on the reduction in likelihood of a higher expenditure of 17.5% (i.e., 
odds of 32.5%), this predictor was most influential in the prediction of emergency room 











Binary Logistic Regression of Emergency Room Expenditures on Race, Age, and 
Covariates 
   Odds ratio   
Source Estimate SE OR 95% CI Wald p 
       
Race: Black (ref: other) 0.03 0.00 1.030  [1.026, 1.035] 13.69 < .001 
Race: White (ref: other) 0.16 0.00 1.176 [1.171, 1.180] 83.77 < .001 
Age: 65 and older (ref: < 64) -0.32 0.00  0.727 [0.726, 0.729] -
384.62 
< .001 
Sex: Male (ref: female) -0.11 0.00 0.899 [0.898, 0.901] -
131.31 
< .001 
Poverty: Poor or low (ref: 
medium or high) 
-0.19 0.00 0.827 [0.826, 0.828] -
232.72 
< .001 
HIV -0.43 0.00 0.653 [0.644, 0.662] -59.99 < .001 
Cardiovascular disease 0.06 0.00 1.063  [1.047, 1.079] 7.89 < .001 
 
Summary 
Results indicated that for each type of expenditure, older participants (i.e., those 
aged 65 and older) had higher odds of incurring higher expenditures. In terms of race, 
White participants had higher odds of having higher expenditures for all categories 
except for medication (in which both Black and White participants had similarly higher 
odds of incurring higher expenditures than other races), and home health (in which White 
participants had higher odds of having lower expenditures).  
Results of multivariate analyses (i.e., multivariate binary logistic regressions) also 
indicated that those with HIV had higher expenditures for home health than their HIV 
negative counterparts, but lower expenditures for emergency room. Individuals with 
cardiovascular disease tended to have higher outpatient, inpatient, and emergency room 
expenditures than their counterparts without cardiovascular disease, but lower office-
based and home health expenditures. When comparing the effects of the predictor 
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variables, race was found to be a significant predictor in terms of outpatient, office-based, 
inpatient, and medication expenditures, where White patients had higher odds of 
incurring higher expenditures in these four categories. In terms of inpatient expenditures, 
cardiovascular disease status was the strongest predictor, with those who were diagnosed 
with cardiovascular disease being, theoretically, 100% likely to have higher expenditures. 
Age was the strongest predictor of home health expenditures, where individuals aged 65 
and older had higher odds of incurring higher expenditures. For emergency room 
expenditures, HIV status was the most predictive, indicating that those with HIV had 
lower odds of incurring a higher expenditure.  
In Section 4, these findings will be interpreted with relation to the existing 
knowledge and the theoretical foundations of the study. The section will also include 
details regarding the limitations of the study, as well as recommendations for future 
researchers who wish to expand further upon the knowledge gleaned from the present 
study. Implications for the professional practice and exposition of how the results can be 
used to enact positive social change will also be discussed so that the full benefit of the 
study’s results can be realized. 
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Section 4: Application to Professional Practice and Implications for Social Change  
Introduction 
In this quantitative study, I investigated whether health care expenditure 
disparities by age and race exist between Blacks and White Americans with a diagnosis 
of HIV or cardiovascular disease. I also examined the effect that type of health service 
had on the total direct medical expenditures incurred for patients with an infectious 
disease (HIV) versus patients with a chronic disease (cardiovascular disease). The key 
findings were that older individuals (i.e., adults aged 65 and older), with either an HIV or 
cardiovascular disease diagnosis, had higher odds of incurring higher total medical 
expenditures (across six household-reported medical events) when compared to 
individuals aged 64 and younger. For the second research question, White Americans, 
with either a diagnosis of HIV or cardiovascular disease, were found to incur higher 
medical expenditures, except for medication, which was a higher medical expenditure for 
both Blacks and Whites when compared to other races. In contrast, White participants 
were found to have lower medical expenditures for home health services when compared 
to Blacks. For the third research question, results for participants with an HIV diagnosis 
showed that these individuals incurred higher medication and home health expenditures 
and lower emergency room expenditures than individuals without HIV. Results also 
showed that individuals with cardiovascular disease had higher odds of experiencing 
higher outpatient, inpatient, and emergency room expenditures, and lower office-based 
and home-health expenditures than individuals without cardiovascular disease.  
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Interpretation of the Findings 
This study both confirms and extends the current knowledge of the financial 
burden individuals with HIV and cardiovascular disease face in the United States. This 
study may be one of the first to compare the financial burden of individuals with a 
diagnosis of HIV or cardiovascular disease in the United States by age and race. 
However, previous research has compared the financial burden of people living with 
HIV/AIDS and those living with other chronic conditions, indicating that longer life 
expectancies and a wider range of medications for both HIV and other chronic conditions 
contribute to higher health care expenditures, particularly among the elderly (Ritchwood 
et al., 2017). Similarly, when the analysis of MEPS data is restricted to adults with two 
chronic conditions (arthritis, diabetes mellitus, heart disease, and hypertension), the type of 
chronic condition impacts average health care expenditures (Merata et al., 2015). 
For Research Question 1, age was the strongest predictor of home health 
expenditures, where those 65 and older had higher odds of incurring higher expenditures. 
Older individuals (i.e., adults 65 years and older) with either an HIV or cardiovascular 
disease diagnosis had higher odds of incurring higher total medical expenditures (across 
the six household-reported medical events analyzed) when compared to individuals aged 
64 and younger. This is supported by previous research such as Janus and Ermisch 
(2015), who found that the odds of home health services use among older people 
increases by a factor of 1.02 (95% CI 1.00-1.03) for each 1-year increase in age. These 
odds ratios are comparable to those reported in this study (odds ratio 1.58 [95% CI 1.58, 
1.59]) and can be used to determine meaningful effect of health care expenditures, 
particularly among older patients. Other research also supports these findings that elderly 
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adults (aged 65 and older) in the United States experience increased levels of economic 
vulnerability, higher cost sharing, and increased health care costs, especially regarding 
prescription drugs, which are often up to 3 times more expensive than in other high-
income countries (Osborn et al., 2017). Additionally, the prevalence of polypharmacy 
among older adults contributes to adverse drug events, resulting in increased health care 
costs and morbidity and mortality (Linjakumpu et al., 2002; Vrettos et al., 2017; Wenger 
et al., 2017). Elderly adults are more susceptible to adverse drug events, which accounts 
for over 170,000 emergency room visits annually, represents 25% of hospital admissions 
among the elderly, and is the fourth leading cause of hospital admissions among this 
adult population (Wenger et al., 2017). These results highlight why health care costs 
among the elderly, aged 65 and older, are higher than individuals aged 64 and under. 
Race and age and the impact on medical expenditures among individuals with a 
diagnosis of HIV or cardiovascular disease were the focus of Research Question 2. When 
comparing the effects of the predictor variables, race was found to be a significant 
predictor in terms of medication (1.251 odds ratio [95% CI 1.248, 1.254]), office-based 
(1.433 odds ratio [95% CI 1.429, 1.436]), inpatient (1.245 odds ratio [95% CI 1.239, 
1.250]), and outpatient (1.451 odds ratio [95% CI 1.446, 1.457]) expenditures, where 
White patients had higher odds of incurring higher expenditures in these four categories. 
Results of the analysis indicated that White Americans with either diagnosis were found 
to incur higher medical expenditures except for medication, which was a higher medical 
expenditure for both Blacks and Whites, and home health services, which was a lower 
medical expenditure for Whites when compared to Blacks. Similar odds ratios were 
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found by Odhiambo, Davis, and Omolo (2017), who examined the risk for cardiovascular 
disease in Blacks with HIV/AIDS in America and determined that an odds ratio of 1.26 
(95% CI 1.22, 1.30) was sufficient to suggest that risk of cardiovascular disease was 
higher among Blacks when compared to Whites. Although these results differed from this 
study, the odds ratio used can be used to determine meaningful effect, because both this 
study and their study produced similar odds ratio values. 
Further addressing the results regarding Research Question 2, a 2018 Kaiser 
Family Foundation study reported that Black Medicare beneficiaries incurred lower 
average out-of-pocket health care costs when compared to their White counterparts. This 
may be due to lower incomes among Black beneficiaries and increased cost sharing 
coverage under Medicaid and Part D low-income subsidy programs when compared to 
Whites, who had substantially higher per capita total income, on average, when compared 
to Blacks (Cubanski, Neuman, Smith & Damico, 2018). The 2016 Census Bureau report 
on poverty, income, and health insurance coverage also suggested that although there was 
an increase in median household incomes across races, the median Black household 
earned 61 cents for every dollar earned within the White median household (Wilson, 
2017). Persons with higher incomes had higher odds of incurring higher health care 
expenditures when compared to individuals with lower incomes, because of their 
increased ability to afford it (Cubanski et al., 2018). 
The third research question addressed whether the type of health care service used 
(based on the six household-reported medical events analyzed) impacted the total medical 
expenditures incurred for patients with a diagnosis of HIV or cardiovascular disease. 
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Analyses showed that individuals with an HIV diagnosis incurred higher medication and 
home health expenditures and lower emergency room expenditures when compared to 
individuals in the cardiovascular disease cohort, who had higher odds of experiencing 
higher outpatient, inpatient, and emergency room expenditures, and lower office-based 
and home-health expenditures than individuals in the HIV cohort. In terms of inpatient 
expenditures, cardiovascular disease status was the strongest predictor, with those who 
are diagnosed with cardiovascular disease being likely to have higher expenditures. For 
emergency room expenditures, HIV status was the most predictive, indicating that those 
with HIV had lower odds of incurring a higher expenditure.  
Limited studies have addressed the financial burden of individuals living with 
HIV/AIDS compared to those living with other chronic conditions. However, Durand et 
al. (2011) found increased odds of acute myocardial infarction among HIV-positive 
patients with odds ratios ranging between 1.79 and 2.29 for acute myocardial infarctions 
associated with any exposure to the antiretrovirals abacavir (1.79 (95% CI 1.16 to 2.76), 
efavirenz 1.83 (95% CI 1.21 to 2.76), lopinavir (1.98 (95% CI 1.24 to 3.16), and ritonavir 
2.29 (95% CI 1.48 to 3.54). These odds ratios are comparable to those reported in this 
study and can be used to determine meaningful effect of health care expenditures, 
particularly among in-patient services use (odds ratio 2.14 [95% CI 2.12, 2.16]), among 
cardiovascular disease patients as it relates to incidence of acute myocardial infarction 
and health care service use. Furthermore, Okunrintemi et al. (2017) reported a 
significantly greater use of health resources among cardiovascular patients (odds ratio 
(emergency room visit), 1.41 [95% confidence interval, 1.09-1.81]; odds ratio 
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(hospitalization), 1.36 [95% confidence interval, 1.04-1.79]). These odds ratios can also 
be used to determine meaningful effect of higher healthcare expenditures among patients 
with cardiovascular disease.  
Despite similar odds ratios from previous studies, Ritchwood et al.’s (2017) study 
is the only one that can be used to compare the results for Research Question 3 because 
of similar analysis components. Among people living with HIV/AIDS, higher 
expenditures were reported for costs of prescription medications and use of in-patient, 
office-based, and home health services (see also Chen et al., 2006; Ritchwood et al., 
2017), which supports the results in this study. Additionally, among individuals living 
without HIV but had a chronic disease (such as cardiovascular disease, diabetes, and 
stroke), the largest percentage of health care costs within this population were incurred 
from in-patient and office-based visits. Their results indicated that the cardiovascular 
disease population sustained higher medical expenditures for inpatient services, which 
was confirmed in this study’s analysis. 
In addition to previous research findings, Andersen’s behavioral model of health 
services use and the socioecological model can be applied to this study’s findings 
regarding older adults and the financial barriers they may encounter in accessing 
adequate healthcare because of enabling/interpersonal factors, predisposing/intrapersonal 
factors, need/institutional and community factors, environmental factors, and policy. For 
example, Osborne et al. (2017) found that older adults in the United States, despite 
having insurance coverage through Medicare, had skipped a recommended treatment or 
medical test, did not fill a prescription, skipped medication doses due to cost, and 
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incurred high cost sharing and out-of-pocket expenses because of copayments and 
deductibles for pharmaceuticals and medical services. In addition to cost, risk factors 
associated with HIV and cardiovascular disease that can impact medication adherence 
include smoking, which has shown consistent documented heightened rates among HIV-
infected patients (Currier et al., 2008; Hemkens & Bucher, 2014) and has been linked to 
increased cardiovascular event risk within the HIV population (Triant, 2013). Other risk 
factors are hypertension, family history of chronic disease, and diabetes mellitus (Currier 
et al., 2008; Oramasionwu et al., 2013). These risk factors can place a financial burden on 
the medical expenditures of adults diagnosed with HIV or cardiovascular disease 
(enabling/interpersonal factors), particularly among those aged 65 and older who may 
already be contending with multicomorbidity and polypharmacy complications. These 
risk factors can also contribute to the perceived barriers to care and receipt of 
recommended medical care from specialized clinicians (need/institutional and community 
factors) among older Medicare beneficiaries (Kurichi et al., 2017). 
In addition to the multiple factors affecting healthcare, policy structures can have 
a direct impact on the ability of adults to absorb the financial costs for medication and 
medical services. Under the Affordable Care Act, individuals with preexisting conditions 
are guaranteed access to health insurance through the individual market (Dawson & 
Kates, 2017). As the debate over the repeal of the Affordable Care Act continues, 
policymakers should consider that changes to current Affordable Care Act legislation can 
result in limited access to health care coverage for individuals with HIV and other pre-
existing conditions (Dawson & Kates, 2017; Obama, 2017), poorer quality of care, and 
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worse short-term outcomes (Wadhera & Joynt, 2017), especially among older adults with 
HIV or cardiovascular disease diagnoses. 
Limitations of the Study 
There are limitations associated with the use of MEPS data for research studies 
which include the self-reporting of diagnoses from survey participants who may 
misunderstand the questions asked, as well as inaccurate and/or underreported reporting 
procedures for both cardiovascular disease and HIV. This study also restricted analysis to 
the use of total direct medical expenditures (outpatient, office-based, medication, 
inpatient, home health, and emergency room), and did not include indirect costs 
associated with HIV and cardiovascular disease diagnoses, such as quality of life and loss 
of productivity (Ritchwood et al., 2017).  
The data for this study is pooled and cannot be used to interpret longitudinal 
trends among this study cohort. The inclusion of insurance type, education, and region of 
residence included in Table 5 are based on descriptive statistics only; and because they 
are not weighted, no statistical inferences can be drawn about the study population. It is, 
therefore, not generalizable to individuals outside the study cohort. Finally, the sample 
used for this analysis only focused on Black and White adults with either a diagnosis of 
HIV or cardiovascular disease. Therefore, due to the narrow characteristics of the 
participants within this study, the results cannot be generalized to other races/ethnicities, 
individuals with other comorbidities and/or diagnoses within the larger population, or 
populations residing outside the United States (see Creswell, 2009).  
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The use of MEPS data presents additional challenges that can impact the 
generalizability of this study. These include: sample sizes that are too small to support 
analyses adequately, insufficient tracking of participants if their circumstances change 
beyond the two-year sampling period; and incomplete imputed payment data, which may 
not be accurately validated from providers due to insufficient data procurement resources 
(Berk & Wilensky, 2016). In this study, the final dataset collected for the expenditure 
variables exhibited negative values, which did not have any true monetary meaning. Such 
values were deleted because they were patient reported medical events that resulted in 
zero payment, thus the expenditure data associated with those entries was deemed 
inapplicable (Agency for Healthcare Research and Quality, 2017b). Incomplete or non-
existent imputed payment data resulted in the removal of inapplicable values which 
allowed participants to be excluded from an analysis when they had a negative value 
without being deleted from the dataset entirely. This allowed participants who had useful 
data for at least one other dependent variable component to be retained for any analysis 
where they had complete data. The inclusion of inapplicable values represents a 
weakness in the use of this dataset as collected. 
Recommendations 
Literature providing cost comparisons of total healthcare expenditures among 
older adults with HIV and/or chronic diseases such as cardiovascular disease in the 
United States is limited. A major knowledge gap identified during the research conducted 
for this study illustrated a lack of literature that highlights the impact of total medical 
expenditures as it relates to older HIV-infected individuals with cardiovascular disease. 
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Chronic disease complications among individuals with long-term HIV diagnoses have 
manifested among this population, even as mortality rates from the disease has declined. 
Cardiovascular disease remains one of the leading causes of death among HIV-infected 
persons (Cournoyer et al., 2016; Hanna et al., 2016; Wenger et al., 2017), as well as the 
leading contributor to disease burden among adults aged 60 and older (Prince et al., 
2015). Amongst individuals aging with HIV, cardiovascular morbidity and mortality 
tends to occur earlier and more frequently among HIV-infected persons, than in 
uninfected individuals (Tseng et al., 2012). Cardiovascular risk in HIV patients can be 
influenced by the following factors: prolonged survival, particularly among older 
patients; higher rates of additional cardiovascular risk factors, principally with regard to 
smoking; and metabolic complications related to HIV and certain components of 
antiretroviral therapy medications that include dyslipidemia, insulin resistance, 
hypertension, higher prevalence of hypercholesterolemia, and increased abdominal 
visceral adiposity (Currier et al., 2008; Gedela et al., 2014; Nsagha et al., 2015). These 
metabolic disturbances, which occur as a result of HIV infection and antiretrovirals, have 
been found to increase ischaemic cardiovascular disease risk among HIV-infected 
persons (Gedela, Vibhuti, Ward, & Boffito, 2014). This is especially prevalent among 
older HIV-infected individuals as they are increasingly subjected to prolonged use of 
certain antiretroviral therapies such as protease inhibitors and nucleoside reverse 




Older individuals have been omitted from clinical trials and studies in favor of 
healthier and younger research candidates because of multicomorbidities and other 
exclusion factors (Jansen, McKinn, Bonner et al., 2015). Data is limited, especially 
within clinical practice guidelines, that sufficiently addresses the health concerns of older 
people, specifically as it relates to cardiovascular disease (Jansen et al., 2015). Although 
various clinical practice guidelines have been developed to address the prevention and 
management of cardiovascular disease within the general population (Petoumenos & 
Worm, 2011; Triant, 2013), very little clinical guidance exists for the elderly population 
even though there is a higher propensity of cardiovascular risk, HIV progression, and use 
of certain HIV medications among older HIV-infected adults (Kebodeaux et al., 2013).  
Cardiovascular disease and older HIV-infected adults 
Older HIV-infected persons can experience a wider range of physical and 
psychosocial problems than younger HIV-infected individuals (Lorenc & Robinson, 
2013). This may be because of later disease diagnosis among this cohort (Balderson et 
al., 2013). In a case-controlled study, Guaraldi et al. (2015) analyzed 404 HIV-aging and 
404 HIV-aged participants against 2424 controls and found that the older HIV-positive 
participants had higher rates of multimorbidity (such as cardiovascular disease) and age-
related chronic conditions when compared to HIV-negative participants within the same 
age range. Similarly, in a longitudinal cohort study of 24, 510 HIV-infected US 
(predominantly male) veterans who were chosen from the Veterans Health 
Administration Clinical Case Registry, researchers found that certain antiretroviral drugs 
and antiretroviral drug combinations had a moderately increased risk in the occurrence of 
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cardiovascular events (Desai et al., 2015). 
Another review of cardiovascular disease risk among aging HIV individuals 
concluded that although there is a decline in immune function with HIV infection and 
age, there is also a multifactorial link between HIV and cardiovascular disease which 
include modalities that are both biological and environmental (So-Armah & Frieberg, 
2014). Additionally, while the researchers found that there is an association between 
increased cardiovascular disease risk and HIV infection, they also determined that 
immune alterations, which are related to atherosclerosis, is also a common characteristic 
of aging, cardiovascular disease, and HIV (So-Armah & Frieberg, 2014).  
In this study I investigated the association of age and race on older adults with either an 
HIV or cardiovascular disease diagnosis. Although research exists that shows that older 
adults diagnosed with HIV also develop concurrent cardiovascular disease diagnoses 
(Friedman & Duffus, 2016; Kim & Richardson, 2014), limited research exists that 
connects cardiovascular disease and HIV. Therefore, future research could explore the 
interconnection between adults (both under and over the age of 65) with a diagnosis of 
both HIV and cardiovascular disease and the corresponding trends in health care 
expenditures among those within the Medicare population. 
Implications for Professional Practice 
As HIV-infected persons continue to live beyond the age of sixty-five, older 
adults will continue to transition into age groups that have an increased prevalence of 
cardiovascular risk and other non-AIDS-defining medical conditions (Nsagha et al., 
2015). Long-term use of cardiovascular drugs, especially among the elderly, introduces 
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new issues impacted by efficacy and safety which are limited by evidence-based studies 
(Rossello, Pocock, & Julian, 2015). 
Implications for professional practice among health care professions, for older 
adults diagnosed with HIV, should focus on: (a) initiating cardiovascular disease risk 
factors assessments prior to the initiation of antiretroviral therapy treatments, followed by 
subsequent periodic monitoring for the duration of treatment (Nsagha et al., 2015); (b) 
optimizing antiretroviral therapy for HIV-infected patients to reduce cardiovascular 
disease risk, while exercising caution for potential drug-drug interactions, particularly 
regarding the use of protease inhibitors and statins (Boccara et al., 2013); (c) coordinating 
care between HIV specialists and cardiovascular disease clinicians to: manage the 
chronic disease component of HIV infection, determine individualized antiretroviral 
therapy combinations based on patient adherence, and ultimately improve prognosis for 
this population (Hemkens & Bucher, 2014); and (d) identifying and addressing cases of 
cultural incompetence among primary providers which may increase the prevalence of 
racial disparities among patients of color, and impact HIV and cardiovascular disease 
treatment outcomes (Price et al., 2014).  
Among older adults with cardiovascular disease diagnoses, professional practice 
coordination can be recommended to address the problems surrounding polypharmacy, 
medication adherence, and adverse drug events (Wenger et al., 2017). Improvements can 
be ascertained by including older adults in clinical studies and the development of 
guidelines that focus on the medical management of cardiovascular disease and HIV, 
while also providing an opportunity for shared decision- making between clinicians and 
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patients within the elderly population to detect and prevent early possible drug reactions 
(Vrettos et al., 2017; Wenger et al., 2017). 
Social Change 
The results of this study indicate that higher health service expenditures across all 
six health service categories (medication, outpatient, office-based, in-patient, home health 
and emergency room services) are associated with aging, particularly among adults aged 
65 and older.  Race is also associated with higher health service expenditures, with 
Whites incurring higher health care costs for medication, outpatient, office-based, in-
patient, and emergency room services when compared to Blacks, who incurred higher 
expenditures for home health services alone. Patients with a diagnosis of cardiovascular 
disease were associated with higher health service expenditures for out-patient, inpatient, 
and emergency room services; while patients with HIV diagnoses were associated with 
higher health service expenditures for home health services. 
This study will inform and improve stakeholder collaboration between different 
components of the United States health care system.  It speaks to a greater need for 
wellness and disease prevention efforts and improved patient understanding for a rapidly 
aging adult population, particularly among those with cardiovascular disease incurring 
increased expenditures.  
The types of health care service analyzed in this study are all provided to patients 
in poor health. Adults aged 65 and older, particularly those with chronic comorbidities 
such as cardiovascular disease and HIV, have generally higher rates of medication 
nonadherence that often leads to increased health risks and worsening of disease (New 
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England Healthcare Institute, 2009) which is associated with higher rates of morbidity, 
mortality, hospital admissions and increased health care costs (Neiman et al., 2018).  A 
CDC report states that for the 3.8 million prescriptions written annually in the U.S., 
approximately one in five of the new prescriptions are never filled; and when patients do 
fill their prescriptions, approximately 50% are taken at the wrong time, duration, 
frequency and dosage (Neiman et al., 2018; Kim et al., 2019 ). Improving medication 
adherence in adults aged 65 and older can reduce the health burdens associated with 
cardiovascular disease (chronic) and HIV disease (infectious disease), while also 
reducing the pervasive economic burden that these conditions have on this population. 
 Findings from this study will promote self-management practices such as 
medication adherence and proactive engagement in health maintenance among adults 
aged 65 and older. It will improve collaborative efforts between clinicians and patients to: 
(a) serve as advocates to assist older adults in the navigation of health care systems. This 
can be accomplished by utilizing clinicians, such as resident physicians and community 
health workers, to work within community integrated health programs to support and 
provide care and education to patients with chronic medical conditions about the 
appropriate use of primary care resources (Prasad et al., 2015; Knox, 2009; American 
Heart Association, 2018b); (b) utilize technology to reduce medication nonadherence 
among older adults. The use of digital technologies such as smartphones, phone apps, and 
wearable devices such as smart watches, are interventions that can be used by clinicians 
to provide reminders to patients to fill/renew prescriptions and take medications when 
needed (Marvel et al., 2018). (c) develop patient navigator programs to educate older 
123 
 
adults and assist in the navigation of and access to health services for individuals with 
chronic diseases. Older adults frequently encounter barriers to accessing available health 
services which can result in medication nonadherence, reduced morbidity and mortality, 
and increased overall health care costs for the use of health services.  Furthermore, 
Rocque et al., (2017) reported that navigated patients experienced reduced costs to 
Medicare and health care use, when compared to non-navigated patients, and saw 
decreased costs for emergency visit services, hospitalizations, and intensive care unit 
admissions.  
The aging of older adults with chronic and infectious diseases, like HIV and 
cardiovascular disease, can result in increased vulnerability to chronic 
multicomorbidities. Additional intensive health services (i.e., primary care and 
preventative care), health care education, integrated and transdisciplinary patient care, 
and shared decision-making between patients and providers will be required to 
adequately address this growing population’s needs and increase their quality of life 
(Barry, 2012; Dawson & Kates, 2017), and life span (Oramasionwu et al., 2013; Spitzer 
& Davidson, 2013).  
Conclusion 
In the United States elderly adults (aged 65 and older) with chronic illnesses 
experience increased levels of economic vulnerability, higher cost sharing, and increased 
health care costs (particularly as it relates to prescription medications) when compared to 
other high-income countries (Osborn et al., 2017). Trends in direct health care 
expenditures among people living with HIV showed that significantly higher costs were 
124 
 
associated with an HIV diagnosis for prescription medications, and the utilization of 
home health, office-based and inpatient services (Ritchwood et al., 2017). For individuals 
with a cardiovascular disease diagnosis, higher expenditures were associated with 
inpatient and office-based services (Ritchwood et al., 2017). These trends mirrored 
certain results reported in this study. 
Results from this study highlight the health care cost disparities that may be 
encountered by older adults living with a chronic disease or an infectious health 
condition, and the inequalities they may face as they age with these diseases. Race and 
age are significant factors in the determination of total direct medical expenditures among 
older adults, particularly among those diagnosed with infectious and chronic diseases like 
HIV and cardiovascular disease. Polypharmacy among older adults has been found to be 
contributor of adverse drug events, resulting in increased health care costs, morbidity and 
mortality risk factors, and increasing medication safety concerns among the elderly 
(Linjakumpu et al., 2002; Vrettos et al., 2017; Wenger et al., 2017). Assessing the 
influences of these factors on infectious and chronic diseases can help address variations 
in medical expenditures across various categories of health care services and can be 
useful in initiating the development of tailored evidence-based practice 
guidelines/strategies that may help in the reduction of cardiovascular disease in HIV-
infected older adults.  
While limited data is available to assess medical expenditure disparities among 
older HIV-infected adults with a concurrent cardiovascular disease, future research can 
further expand the knowledge of this subject by evaluating whether (a) inequalities exist, 
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by race and age, among older adults within this population, and (b) whether variations in 
health care costs among older HIV-infected adults with cardiovascular disease exist by 
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AHRQ MEPS Survey Data Dictionary 










AGELAST Person’s age last time eligible 
 
0 - 4 AGE    
5 - 17 AGE    
18 - 24 AGE    
25 - 44 AGE   
45 - 64 AGE   
65 - 85 AGE 
Independent 
variable 
RACEV1X Race reported by respondents 1 WHITE    
2 BLACK   
3 AMER INDIAN/ALASKA 
NATIVE   
4 ASIAN/NATV 
HAWAIIAN/PACFC ISL-  
6 MULTIPLE RACES REPORTED 
Independent 
variable 
FAMINC Total income by family -$48,666 - -$2,789    
0.00       
$1 - $22,200      
$22,201 - $44,724     
$44,725 - $82,006     
$82,007 - $542,785    
Dependent 
variable 
POVCAT Family income as % of poverty 
line 
1 POOR/NEGATIVE     
2 NEAR POOR     
3 LOW INCOME   
4 MIDDLE INCOME   
5 HIGH INCOME 
Independent 
variable 
INSURCC Full year insurance coverage 
status 
1 <65 ANY PRIVATE    
2 <65 PUBLIC ONLY   
3 <65 UNINSURED    
4 65+ EDITED MEDICARE ONLY 
   
5 65+ EDITED MEDICARE AND      
PRIVATE 
6 65+ EDITED MEDICARE AND 
OTH PUB ONLY    










MCRJA Covered by Medicare -1 INAPPLICABLE     
1 YES       
2 NO    
Independent 
variable 
EDURECODE Level of Education -9 NOT ASCERTAINED  
-8 DK  
-7 REFUSED  
-1 INAPPLICABLE OR UNDER 5  
1 LESS THAN/EQUAL TO 8TH 
GRADE  
2 9 - 12TH GRADE, NO HS 
DIPLOMA OR GED  
13 GED OR HS GRAD  
14 BEYOND HS,COLLEGE(NO 
4YR DEG),ASSOC DEGREE  
15 4-YEAR COLLEGE DEGREE, 
BACHELOR'S DEGREE  




REGION Region of residence -1 inapplicable;  
1 Northeast;  
2 Midwest;  






 Clinical classification code 
(CCCODEX) 
 
(100  ACUTE MYOCARDIAL 
INFARCTION   
101  CORONARY 
ATHEROSCLEROSIS AND 
OTHER HEART  
103  PULMONARY HEART 
DISEASE    
104  OTHER AND ILL-
DEFINED HEART DISEASE  
106  CARDIAC 
DYSRHYTHMIAS   




 HIV Infection  Clinical classification code 
(CCCODEX) 




• Hospital inpatient stay (IP) 
• Emergency room visits (ER) 
• Office based medical provider 
visits (OB) 
• Home health visits (HH) 
• Outpatient visits (OP) 































7.Other Federal Sources  
– includes Indian Health Service,  
military treatment facilities,  
and other care by the federal 
government, 
8.Other State and Local Source – 
includes community and 
neighborhood clinics, state and 
local health departments, and 
state programs other than 
Medicaid,  
9. Workers’ Compensation, and  
10. Other Unclassified Sources  
– includes sources such as 
automobile, homeowner’s,  
and liability insurance, and other 
miscellaneous or unknown 
sources.  
• SF - self or family 
• MR - Medicare 
• MD - Medicaid 
• PV - private insurance 
• VA - Veterans 
Administration/CHAMPVA 
• TR - TRICARE OU - other 
public 
• OF - other federal 
government 
• SL - state/local government 
• WC - Workers’ 
Compensation 
• OT - other insurance 
• OR - other private 
• XP - sum of payments 
Dependent 
variable 
  
